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Abstract
Developing B and T lymphocytes must rearrange the genomic sequence of antigen receptor genes by
V(D)J recombination. The lymphocyte-specific endonuclease RAG, composed of Rag1 and Rag2, initiates
this process by cleaving specific sites within antigen receptor loci. RAG expression must be carefully
regulated to ensure that V(D)J recombination occurs only under appropriate circumstances. The Bassing
laboratory has previously demonstrated that Igκ locus cleavage by RAG in pre-B cells initiates a feedbackinhibition signal suppressing RAG expression. Here, we show that DNA double strand breaks (DSBs)
induced by a variety of genotoxic agents have a similar effect in suppressing mRNA expression of Rag1
and Rag2. This effect can be observed in pro-B cells, pre-B cells, and DN thymocytes, but is not found in
DP thymocytes. Using primary pre-B cells as a model system, we show that DSBs activate ATM and Nemo
to rapidly suppress transcription of Rag1 and Rag2. In pre-B cells, loss of Rag1 and Rag2 mRNA
expression leads to loss of Rag1 protein, but Rag2 protein is more stable and persists in the absence of
Rag2 mRNA. Suppression of Rag1 expression by DSBs is associated with suppressed RAG-mediated
cleavage of the Igκ locus or an artificial recombination substrate in Abelson-transformed pre-B cells.
However, simply over-expressing Rag1 does not allow cells to complete V(D)J recombination in the
presence of DSBs, suggesting that other factors may also play a role in suppressing V(D)J recombination.
Parallel studies indicate that that RAG-induced DSBs created during V(D)J recombination activate this
suppressive signal to enforce allelic exclusion of IgH, TCRβ, and Igκ antigen receptor proteins. We
discuss the importance of Rag1 and Rag2 suppression in the context of allelic exclusion and propose a
role in maintaining genomic stability of developing B and T lymphocytes.
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ABSTRACT

DNA DOUBLE STRAND BREAKS SUPPRESS EXPRESSION OF THE RAG RECOMBINASE:
MECHANISMS AND CONSEQUENCES
Megan R. Fisher
Craig H. Bassing
Developing B and T lymphocytes must rearrange the genomic sequence of antigen
receptor genes by V(D)J recombination. The lymphocyte-specific endonuclease RAG,
composed of Rag1 and Rag2, initiates this process by cleaving specific sites within
antigen receptor loci. RAG expression must be carefully regulated to ensure that V(D)J
recombination occurs only under appropriate circumstances. The Bassing laboratory has
previously demonstrated that Igκ locus cleavage by RAG in pre-B cells initiates a
feedback-inhibition signal suppressing RAG expression. Here, we show that DNA double
strand breaks (DSBs) induced by a variety of genotoxic agents have a similar effect in
suppressing mRNA expression of Rag1 and Rag2. This effect can be observed in pro-B
cells, pre-B cells, and DN thymocytes, but is not found in DP thymocytes. Using primary
pre-B cells as a model system, we show that DSBs activate ATM and Nemo to rapidly
suppress transcription of Rag1 and Rag2. In pre-B cells, loss of Rag1 and Rag2 mRNA
expression leads to loss of Rag1 protein, but Rag2 protein is more stable and persists in
the absence of Rag2 mRNA. Suppression of Rag1 expression by DSBs is associated with
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suppressed RAG-mediated cleavage of the Igκ locus or an artificial recombination
substrate in Abelson-transformed pre-B cells. However, simply over-expressing Rag1
does not allow cells to complete V(D)J recombination in the presence of DSBs,
suggesting that other factors may also play a role in suppressing V(D)J recombination.
Parallel studies indicate that that RAG-induced DSBs created during V(D)J recombination
activate this suppressive signal to enforce allelic exclusion of IgH, TCRβ, and Igκ antigen
receptor proteins. We discuss the importance of Rag1 and Rag2 suppression in the
context of allelic exclusion and propose a role in maintaining genomic stability of
developing B and T lymphocytes.
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Chapter 1: Introduction
Requirements of the Immune System
All organisms must recognize and react to foreign species that may attempt to
colonize them. In many cases the colonizing species may harm or even kill its host, such
as the wide variety of pathogens that cause diseases ranging from the common cold to
smallpox. In other cases, the relationship between host and colonizer is innocuous or
even mutually beneficial, as in the case of the human digestive tract, which relies on a
variety of resident bacteria to help break down food into nutrients that human cells can
metabolize (Quigley, 2013). An immune system must distinguish between components
of the organism (self) and foreign entities (non-self) and neutralize potentially
dangerous invaders while minimizing damage to the organism itself and tolerating
foreign organisms that benefit their host.
Immune systems employ a wide variety of methods to detect non-self organisms
and determine how to respond to them. Components of the immune system are
traditionally categorized as "innate" or "adaptive" depending on how specific the
response is to a particular stimulus. Innate immune responses are activated when cells
recognize characteristic components of a particular class of pathogens, and activate a
response targeted to that kind of pathogen. For example, cell-surface receptors that
recognize chemicals in the bacterial cell wall would activate an anti-bacterial response if
1

they detect bacteria where there should be no bacteria. Similarly, intracellular receptors
can detect viral DNA or RNA in a host cell's cytoplasm and activate an anti-viral
response. Innate immune responses allow rapid responses to pathogens that an
organism is pre-programmed to recognize (Brubaker et al., 2015).
However for humans and many other species, innate immunity alone cannot
protect the organism from the wide variety of pathogens encountered in daily life
(Fischer, 2000). Adaptive immunity allows an organism to recognize unique features of a
particular foreign substance, known as antigens. In concert with innate immune
components, adaptive immunity allows highly specific, effective responses targeted to
particular pathogens (Bonilla and Oettgen, 2010). In humans and other jawed
vertebrates, the huge variety of antigen receptors required for adaptive immunity is
generated by the process of V(D)J recombination, in which developing B and T
lymphocytes rearrange parts of their antigen receptor genes to create unique receptors
(Brack et al., 1978; Hedrick et al., 1984a). This process allows each new B or T cell to
recognize a different, almost random antigen, so that the full repertoire of B and T cells
is capable of recognizing a vast array of unknown antigens with high specificity. Because
this process is largely random, many of the receptors produced are autoreactive,
meaning they bind to components of the host organism and could theoretically initiate
an immune response to the organism itself. Developing lymphocytes must pass through
several selection steps that either cause autoreactive lymphocytes to die or otherwise
2

prevent them from being activated by their cognate antigen. Failure of these selection
steps can lead to autoimmune diseases or immunodeficiencies (von Boehmer and
Melchers, 2010).
Basic Mechanisms of V(D)J recombination
There are several antigen receptor loci capable of undergoing V(D)J
recombination in mammals. In general these loci are composed of many variable (V)
segments and several joining (J) segments. Certain loci also have several diversity (D)
segments located between the V and J segments. In addition to these segments that
encode the variable antigen-recognition sections of an antigen receptor, constant
regions (C) encode non-variable regions of the receptor necessary for signaling
(Tonegawa, 1983; Hedrick et al., 1984b). Before rearrangement V, D, and J segments
span a genomic distance of up to 2.5 megabases. Each of these V, D, and J segments are
flanked by recombination signal sequences (RSSs) (Sakano et al., 1979). RSSs are
composed of three components. Directly adjacent to the antigen receptor gene segment
is a highly conserved seven base-pair heptamer. Next to the heptamer is a poorlyconserved spacer of either 12 or 23 base pairs, followed by a conserved nonamer. An
endonuclease complex composed of Rag1 and Rag2 (RAG) binds to and cleaves at RSSs
adjacent to two different gene segments, creating a DNA double-strand break (DSB)
directly adjacent to each segment (McBlane et al., 1995). Processing of these breaks can
3

lead to loss and/or addition of several nucleotides at the break site. Finally, nonhomologous end joining (NHEJ) factors rearrange and repair the DSBs so that the two
selected gene segments are directly adjacent to each other in the repaired DNA
sequence (Helmink and Sleckman, 2012). This may be accomplished by removing
intervening DNA if the selected DNA segments were in the same orientation in the
germline DNA (rearrangement by deletion; Figure 1.1). Alternatively, if the two gene
segments were originally in opposite orientations, a section of DNA ending with one of
the segments is flipped to bring the two selected segments into proximity
(rearrangement by inversion). In either case, the repairs are made such that one repair
site includes both gene segments (a coding join) and the other repair site includes both
RSSs (a signal join) (Helmink and Sleckman, 2012).
Generally speaking, lymphocytes attempt rearrangement of only one antigen
receptor locus at a time (Chan et al., 2013; Chaumeil et al., 2013; Hewitt et al., 2009).
However, if an initial rearrangement is non-functional, the cell may subsequently
attempt to rearrange the homologous antigen receptor allele, or create additional
rearrangements on the first allele. Because nucleotides can be randomly added to or
removed from the coding ends of the DSB intermediates, two-thirds of all
rearrangements are out-of-frame and therefore non-functional. Inclusion of a stop
codon or use of a pseudogene segment in the rearrangement can also produce nonfunctional antigen receptor genes (Helmink and Sleckman, 2012). Only a functionally
4

rearranged antigen receptor gene that can produce a protein product expressed on the
cell surface can promote lymphocyte survival and development (Miosge and Goodnow,
2005).
At each stage of lymphocyte development, the expression of the V(D)J catalyst
(RAG) and the accessibility of the substrate (antigen receptor genes) are each carefully
regulated to ensure that the appropriate genes are rearranged at the appropriate time.
Antigen receptor genes must be prepared for rearrangement in the appropriate
developmental stage by undergoing a process of histone modification, precise
nucleosome positioning, and DNA-looping to bring distant gene segments into close
proximity (Proudhon et al., 2015). Similarly, RAG expression is strictly limited to B and T
cells at appropriate developmental stages (Nagaoka et al., 2000). Different transcription
factors and cis-regulatory elements drive Rag1 and Rag2 expression in developing B and
T cells, but in both cell types rearrangement and subsequent cell surface protein
expression of the appropriate antigen receptor gene suppresses further transcription of
Rag1 and Rag2 (Nagaoka et al., 2000).
An overview of B and T lymphocyte development
V(D)J recombination is absolutely required for B and T cell development, as
failure to produce a functional antigen receptor leads to complete developmental arrest
of lymphocyte progenitors (Mombaerts et al., 1992a; Shinkai et al., 1992). Lymphocyte
5

development itself is a complex process in which cells progressively commit to a specific
developmental pathway. Transcription factor networks must guide cells down different
pathways while integrating environmental cues such as availability of cytokines (Lin et
al., 2010). Within this context, V(D)J recombination is regulated to promote the creation
of functional antigen receptor genes at the appropriate stages of lymphocyte
development (Fig. 1.2).
Both B and T cells develop from a common precursor. Commitment to the B
lymphocyte lineage requires a number of transcription factors including Ikaros, E2A,
early B-cell factor (EBF1), and Pax-5 (Lin et al., 2010). Among other important functions,
many of these factors regulate V(D)J recombination in pro-and pre-B cells (Hsu et al.,
2003; Reynaud et al., 2008). These factors are important both for inducing or
suppressing expression of the RAG recombinase and for preparing specific antigen
receptor loci for recombination.
Pro-B cells first rearrange one Immunoglobulin Heavy Chain (IgH) gene (Alt et al.,
1984). An in-frame, functional rearrangement leads to cell surface of the pre-B cell
receptor (pre-BCR), composed of the newly produced IgH chain in complex with the
invariant surrogate light chains. The pre-BCR sends signals that inhibit further IgH
rearrangement and trigger proliferation and progression to the pre-B cell stage
(Übelhart et al., 2015). If the first IgH rearrangement is non-functional, the cell will
6

attempt to rearrange the second IgH allele; if this second attempt creates a productive
IgH gene then development proceeds, but if it is unproductive the cell dies. Cells that do
proceed to the pre-B cell stage eventually cease proliferating, and begin to rearrange
the light chain genes, Igκ and then Igλ (Coffman and Weissman, 1983). Like at the pro-B
cell stage, failure to produce a functional light chain gene leads to cell death. Creation of
a functional light chain capable of binding to IgH and allowing cell surface expression of
a BCR prevents further recombination and causes progression to the immature B cell
stage (Melchers et al., 1995). The antigen-recognition portion of the BCR is a
heterotetramer containing two IgH chains and two IgL (either Igκ or Igλ) chains (Pleiman
et al., 1994). Immature B cells expressing a BCR that recognizes self-antigens may
undergo receptor editing, in which they further rearrange their light chain genes in an
attempt to produce a non-autoreactive BCR (Gay et al., 1993; Tiegs et al., 1993).
Developing T cells go through a similar process in which CD4 CD8 double
negative (DN) thymocytes rearrange the T Cell Receptor β (TCRβ) gene or TCRγ and
TCRδ genes. Formation of a complete γδTCR leads to γδT cell development, while
functional rearrangement of TCRβ promotes progression to the CD4 CD8 double positive
(DP) thymocyte stage (Mombaerts et al., 1992b; Xiong and Raulet, 2007). DP
thymocytes continuously rearrange TCRα genes until they produce a functional alpha
chain capable of binding the TCRβ chain and allowing cell surface expression and
signaling of the αβTCR by weakly binding MHC presented on thymic epithelial cells
7

(Mombaerts et al., 1992b; Klein et al., 2014). Failure to create a functional αβTCR leads
to "death by neglect", while DP thymocytes expressing a receptor that activates
relatively strong signaling may either die or become regulatory T cells that suppress
immune activation (Jordan et al., 2000, 2001; Apostolou et al., 2002)
Allelic exclusion in lymphocytes
As with all autosomal genes, cells contain two alleles of each antigen receptor
gene. If nothing prevented the expression of multiple receptor chains within the same
cell, we would expect these two alleles to rearrange and produce unique antigen
receptor chains, leading to expression of multiple antigen receptors on the cell surface.
The most extreme case would be a B cell that productively rearranged both IgH, both
Igκ, and all Igλ alleles; because an individual receptor contains two IgH and two IgL
chains, this cell could express receptors including dozens of combinations of IgH and IgL
chains on its cell surface. However, it has long been recognized that this is not the case;
instead, most antigen receptor chains are "allelically excluded", meaning an individual
cell expresses protein from only one allele. Most B cells express one IgH and IgL chain
(Cebra et al., 1966; Pernis et al., 1965). Most T cells express one TCRβ chain, although
TCRα is an exception and does not seem to be allelically excluded (Casanova et al., 1991;
Padovan et al., 1993). It is important to note that allelic exclusion was originally defined
by cell surface expression of a single antigen receptor . Later, it was found that allelic
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exclusion is frequently enforced at the level of gene rearrangement, as lymphocytes
usually contain only one productive rearrangement for each antigen receptor chain (Alt
et al., 1984; Casanova et al., 1991). However, a cell that is "included" at the genetic
rearrangement level may still "exclude" at the level of cell surface receptor expression,
as several factors may prevent an apparently functional antigen receptor chain from
being expressed on the cell surface (ten Boekel et al., 1998; Sant’Angelo et al., 2001;
Steinel et al., 2010).
Although allelic exclusion of antigen receptors was discovered over 50 years ago,
it is still unclear why it is enforced. An allelically included lymphocyte would express
receptors with different specificities on its cell surface. One potential disadvantage of
this situation would be inefficient negative selection of allelically included cells
expressing both a self-reactive receptor and an innocuous receptor. Studies utilizing
transgenic expression of self-reactive antigen receptors show that this is technically
possible, but while the "autoreactive cells" can be stimulated by self antigen ex vivo
(Iliev et al., 1994; Zal et al., 1996), only one study reported autoimmune disease
resulting from these cells (Sarukhan et al., 1998). However these studies are limited by
the extreme skewing to a single autoreactive receptor, a situation that is not reflective
of the diverse antigen receptor repertoire found in healthy individuals. At the same
time, it must be recognized that normal individuals do have many allelically included
cells, which generally do not harm that individual. Attempting to address this fact,
9

certain studies have investigated the autoreactive potential of naturally occurring
allelically included lymphocytes. Two groups studying different strains of lupus-prone
mice came to conflicting conclusions regarding the ability of dual-reactive B cells to
promote autoimmunity; it was suggested that differences in tolerance checkpoints
between the two models might affect the degree to which allelically included B cells are
activated and mediate disease (Fournier et al., 2012; Makdasi and Eilat, 2013). A study
examining B cells from healthy mice found that cells expressing two Igκ chains were
more likely than single expressers to produce anti-nuclear reactive antibodies, a
common screen for self-reactivity (Casellas et al., 2007). More recently, it was found
that preventing the normal allelic inclusion of TCRα by deleting one TCRα constant
region allele reduced the frequency of T cells responding to an auto-antigen (Ni et al.,
2014). While these results suggest that allelically included cells may be overrepresented
in the pool of self-reactive lymphocytes, they also highlight the fact that peripheral
tolerance mechanisms are usually sufficient to restrain the autoreactive potential of
either allelically excluded or included lymphocytes. However, it is possible that normal
allelic exclusion represents a "good enough" situation which prevents other tolerance
mechanisms from being overwhelmed, and that loss of allelic exclusion might disrupt
this balance.

10

DSBs and allelic exclusion
During Igκ recombination in pre-B cells, RAG-mediated DSBs at one Igκ allele
activate the DNA damage response protein Ataxia Telangiectasia Mutated (ATM) to
prevent cleavage of the second allele (Steinel et al., 2013). ATM deficiency allows
simultaneous rearrangement of Igκ alleles; in this context, the frequency of B cells
expressing two unique Igκ chains approximately doubles. These results suggest that
monoallelic rearrangement enforced by ATM activation is an important factor in allelic
exclusion of Igκ. As described in Chapter 4 of this work, we show that ATM deficient B
cells also have increased inclusion of the IgH chain, and ATM deficient T cells have
increased inclusion of TCRβ, suggesting that a similar mechanism operates in pro-B cells
and DN thymocytes.
Different genetic elements regulate Rag transcription during B and T cell development
Early in the search for Rag1 and Rag2 promoters and enhancers, two general
themes emerged. One, it was found that Rag1 and Rag2 are generally co-expressed (Yu
et al., 1999). This is unsurprising, as the two genes are located in close proximity and
could easily be regulated by the same genetic elements. Secondly, it quickly became
clear that different sites are important for Rag expression in developing B vs. T cells, and
in some cases DN vs. DP thymocytes (Monroe et al., 1999; Yu et al., 1999; Wei et al.,
2002). A schematic of the Rag1/Rag2 gene locus with known genetic regulatory
11

elements and trans-acting factors is shown in Fig. 1.3. As discussed below, promoter
binding sites for different transcription factors are required in B vs. T cells, and only a
few factors have been shown to bind in both B and T cells. In all cases, enhancer
elements are required for efficient Rag1 and Rag2 expression in vivo. Developing B cells
and DP thymocytes seem to use two entirely distinct sets of enhancers to drive Rag1
and Rag2 transcription, while DN thymocytes use enhancers from each set.
The Rag1 promoter was the first element identified. Interestingly, in luciferase
assays it can drive limited transcription in mature lymphocyte lines and non-lymphoid
cells, in contrast to the restricted pattern of endogenous Rag1 mRNA expression (Brown
et al., 1997; Fuller and Storb, 1997). This may be partially due to the fact that the
widely-expressed transcription facto NF-Y seems to be involved in Rag1 promoter
activity (Brown et al., 1997; Fuller and Storb, 1997). Therefore, it is believed that
endogenous Rag1 transcription must require enhancer elements that are only active in
developing lymphocytes. In contrast to the Rag1 promoter, Rag2 promoter activity
seems to be intrinsically limited to developing B and T cells (Lauring and Schlissel, 1999;
Kishi et al., 2000; Fong et al., 2000). This might be due to a requirement for B and/or T
cell restricted transcription factors for promoter activity.
In addition to their promoters, Rag1 and Rag2 transcription is affected by a
variety of enhancer elements, and all of these elements are preferentially active in
12

either B or T cells. Four enhancers, all located 5' of the Rag2 gene, and one silencer
element located between the Rag1 and Rag2 genes have been identified. Two of these
elements, the Ep and Erag enhancers, demonstrate activity only in developing B cells
(Hsu et al., 2003; Wei et al., 2005). The D3 enhancer (also called Ed) is active in pro-B
and pre-B cells and in DN thymocytes (Wei et al., 2002). Finally the anti-silencer element
(ASE) required to overcome the effect of an active intergenic silencer is absolutely
required for Rag1 and Rag2 expression in DP thymocytes, is partially responsible for
expression in DN thymocytes, but seems to play no role in Rag1 and Rag2 expression in
developing B cells (Yannoutsos et al., 2004).
The Erag enhancer is located approximately 22kb 5' of the first Rag2 exon (Hsu
et al., 2003). Mutation of the endogenous Erag enhancer decreases Rag1 and Rag2
mRNA expression in pro-B, pre-B, and immature B cells, leading to decreased B cell
development; however this mutation has no effect on thymocyte development or Rag1
and Rag2 expression in either DN or DP thymocytes (Hsu et al., 2003). Erag is also
important for Rag1 and Rag2 expression at the earlier common lymphocyte progenitor
(CLP) stage of development (Borghesi et al., 2005).
The Ep enhancer is the most proximal enhancer to the Rag1 and Rag2 genes,
located approximately 2.6 kb 5' of the first Rag2 exon. Ep was identified as one of three
DNase-hypersensitive sites found in lymphocyte cell lines upstream of the Rag2 gene
13

(Wei et al., 2002). The effect of the Ep enhancer on endogenous Rag1 and Rag2
transcription has not been tested, but a transgenic construct containing GFP under the
control of the Rag2 promoter and Ep was shown to drive GFP expression in both B220+
IgM- and B220+ IgM+ bone marrow cells, corresponding to pro- and pre-B cells vs.
immature and mature B cells (Wei et al., 2005). GFP expression was also found in B220+
splenic B cells, which do not normally express Rag1 and Rag2, suggesting that a third
factor normally blocks Ep-driven transcription in these cells (Wei et al., 2005).
The Ed (or D3) enhancer was identified in the same DNase-hypersensitivity
screen as the Ep enhancer. It is located approximately 8 kb 5' of the Rag2 gene. Unlike
Ep, Ed promotes Rag2 promoter activity in both developing B cells and in DN
thymocytes, but has no activity in mature lymphocytes (Wei et al., 2002).
The anti-silencer element (ASE) is the only enhancer-like element known to
affect Rag1 and Rag2 expression in DP thymocytes. It is also the most distant element,
located between 71 and 86 kb 5' of the Rag2 gene (Yannoutsos et al., 2004). It acts by
overcoming the effects of the intergenic silencer element located between the Rag1 and
Rag2 genes (Yannoutsos et al., 2004). In ASE knock-out mice, the silencer element
almost completely prevents Rag1 and Rag2 expression in DP thymocytes. Absence of
the ASE also decreases Rag1 and Rag2 expression in DN thymocytes, although less
drastically. Experiments using GFP-reporter constructs showed that the silencer does
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not prevent Rag expression in developing B cells (Yannoutsos et al., 2004; Yu et al.,
1999).
Transcription factors bind that Rag1 and Rag2 gene regulatory elements
Just as different genetic elements drive Rag1 and Rag2 transcription in
developing B and T cells, the transcription factors that bind to these elements are
mostly distinct between the two lineages. A comprehensive list of the many factors
known to bind the Rag1/Rag2 gene locus is provided in Fig. 1.3. Unfortunately these
factors have been identified in a fairly piecemeal fashion, and so it is difficult to draw a
coherent picture of their relative importance in normal developing lymphocytes. Early
experiments mostly relied on EMSA to show that factors can bind Rag1 and Rag2
regulatory sequences in vitro; more recently ChIP has been used to show that some of
these factors actually do bind these regulatory sequences in vivo. In most cases,
luciferase experiments showed that individual factors have the potential to promote (or
in a few cases inhibit) Rag1 and Rag2 transcription. However knock-out mouse models
of these factors often show no effect on Rag1 and Rag2 mRNA expression, or may even
show the opposite effect of what was predicted by luciferase experiments. The
following sections will briefly summarize the findings for several factors that have been
implicated in regulating Rag1 and Rag2 expression in either developing B or T cells, or in
both.
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Many of the factors shown to bind the Rag1/Rag2 gene locus in developing B
cells are critical for B cell development in general, including Pax-5, E2A, Ikaros, Bcl11a,
and Foxo1 (Bain et al., 1994; Nutt et al., 1997; Dengler et al., 2008; Reynaud et al., 2008;
Lee et al., 2013). All have been shown to promote Rag1 and/or Rag2 transcription in
luciferase assays (Amin and Schlissel, 2008; Fuller and Storb, 1997; Hsu et al., 2003;
Lauring and Schlissel, 1999; Lee et al., 2013); however knockouts of these factors
produce a variety of results. Pax-5 knockout pro-B cells apparently have normal Rag1
and Rag2 expression, although their development is arrested due to other defects (Nutt
et al., 1997). E2A knockout fetal liver was shown to lack Rag1 and Rag2 expression,
although this might be because few cells developed to stages where Rag expression is
expected to by high (Bain et al., 1994); another paper showed that an E2A knockout preB cell line expressed normal levels of Rag1 and Rag2 mRNA (Lazorchak et al., 2006). On
the other hand, Rag1 and Rag2 mRNA expression is impaired in Foxo1, Ikaros, and
Bcl11a knockouts, suggesting that these factors are more crucial for Rag1 and Rag2
expression (Dengler et al., 2008; Reynaud et al., 2008; Lee et al., 2013). Complicating
matters, several of these factors can also regulate the expression of other factors
involved in Rag1 and Rag2 transcription. For example, both Ikaros and Bcl11a can
regulate Foxo1 expression, and so their impact may not entirely be direct (FerreirósVidal et al., 2013; Lee et al., 2013) Ikaros can also suppress expression of the only known
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factor that directly inhibits Rag1 and Rag2 transcription in B cells, Gfi1b (Schulz et al.,
2012; Ferreirós-Vidal et al., 2013).
When studies examining Rag1 and Rag2 transcription differentiate between proand pre-B cells, they often find little difference between the two stages. In contrast,
there are several differences between DN and DP thymocytes. The Ed enhancer can
drive reporter gene expression in DN but not DP thymocytes, and transcription factor
C/EBP can increase Ed activity in luciferase assays (Wei et al., 2002). Active NFAT
appears to suppress Rag1 and Rag2 expression by binding to several sites within the
locus in DN cells, but an effect in DPs has not been reported (Patra et al., 2006). In DP
thymocytes, the ASE is critical for Rag1 and Rag2 expression, but it is less important in
DN thymocytes. The ASE is required to overcome the effects of the intergenic silencer,
whose effects are believed to be mediated by Runx (Yannoutsos et al., 2004). The
protein SATB1, which can be involved in attaching DNA to the nuclear matrix and in
forming loops between DNA regions, is required to bring the ASE and the Rag1 and
Rag2 promoters into close proximity. SATB1-deficiency reduces Rag1 and Rag2
expression in DP but not DN thymocytes, although not quite as drastically as ASE
deletion (Hao et al., 2015; Yannoutsos et al., 2004).
To date, few factors have been found to bind the Rag1/Rag2 gene locus in both
B and T lineage cells: Sp1 (Miranda et al., 2002), NF-Y (Brown et al., 1997; Fuller and
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Storb, 1997), Lef-1 (Okamura et al., 1998; Jin et al., 2002), and c-myb (Fong et al., 2000;
Wang et al., 2000; Kishi, 2002; Miranda et al., 2002). However none of these factors
have been reported to be essential for Rag1 and Rag2 expression in either B or T cells.
Sp1 is a ubiquitously expressed transcription factor that may increase the effectiveness
of lymphocyte-specific factor in activating Rag1 and Rag2 transcription (Miranda et al.,
2002). NF-Y is active in many tissues and can drive Rag1 promoter activity in luciferase
assays using developing B or T cell lines (Brown et al., 1997; Fuller and Storb, 1997).
However its effect on endogenous Rag1 expression has not been reported. Lef-1
knockout thymocytes also express Rag1, although this may be due to a compensatory
effect of TCR-1; ex vivo cultured double knock-out thymocytes express only low levels of
Rag1 mRNA. However they are also largely arrested at a developmental stage in which
high Rag1 expression is not expected, making this result difficult to interpret (Okamura
et al., 1998). Finally, c-myb overexpression was actually shown to decrease Rag1 and
Rag2 mRNA expression, although the effect is likely indirect (Timblin and Schlissel,
2013).
As shown above, many factors have been identified that bind to the Rag1/Rag2
gene locus and seem to regulate its activity. Many of the factors that apparently have
the ability to promote Rag1 and Rag2 transcription as measured by luciferase assays do
not actually seem required to do so in developing lymphocytes. This may be due to
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compensation between factors, so that most transcription factors that bind the
Rag1/Rag2 gene locus and promote transcription are not absolutely essential.
Signaling pathways that regulate Rag expression: PI3K-Akt-Foxo1
One of the most critical direct regulators of Rag1 and Rag2 transcription in
developing B cells seems to be Foxo1. Critical factors for B lineage commitment and
development, such as Ikaros, E2A, and EBF1 (Reynaud et al., 2008; Lin et al., 2010),
promote Foxo1 expression. Foxo1 binds to the Erag enhancer in pre-B cells, and Foxo1
deficient cells have low Rag1 and Rag2 mRNA expression. Foxo proteins are rendered
transcriptionally inactive and degraded via phosphorylation by Akt (Biggs et al., 1999).
Accordingly, the activity of Akt and its upstream activator PI3K suppress Rag1 and Rag2
expression in pre-B cells (Amin and Schlissel, 2008), while PTEN, a negative regulator of
Akt, promotes Rag1 and Rag2 expression (Alkhatib et al., 2012). As both the pre-BCR
and BCR activate PI3K, this pathway is believed to be involved in the suppression of
Rag1 and Rag2 expression upon formation of a productive immunoglobulin heavy chain
or light chain (Amin and Schlissel, 2008; Werner et al., 2010).
Signaling pathways that regulate Rag expression: Mapk/Erk
Erk signaling has been implicated in suppressing Rag1 and Rag2 expression in
both developing T and B cells. In Jurkat T cells and thymocytes, it was shown that tonic
TCR signaling activates the Erk and Abl kinases, which cooperate to suppress Rag1 and
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Rag2 mRNA expression (Roose et al., 2003). Similarly, in developing B cells it was found
that either active or tonic signaling from the BCR activates Erk in addition to the Akt
pathway described above, and that these two pathways cooperate in suppressing Rag1
and Rag2 transcription factors. In this context, Erk activity reduced E2A binding to the
Erag enhancer (Novak et al., 2010).
Signaling pathways that regulate Rag expression: NF-κB
NF-κB signaling plays a fundamental role in lymphocyte development, among
other immune system functions. The family of NF-κB transcription factors includes 5
members which can form a variety of transcriptionally active of homo- or heterodimers
(Hayden and Ghosh, 2012). Three of these proteins (RelA/p65, RelB, and c-Rel) contain
transactivation domains and can promote transcription when bound to a gene locus.
The other two (NFKB1/p50 and NFKB2/p52) lack transactivation domains, and can only
promote transcription as part of a heterodimer in which the other partner contains a
transactivation domain (Hayden and Ghosh, 2012). Although an "NF-κB consensus site"
has been defined, different dimers may preferentially bind to somewhat different DNA
sequences (Wong et al., 2011).
NF-κB signaling is often generalized as either canonical or non-canonical,
depending on the activation pathway and the particular dimer pairs activated by the
signal (Hayden and Ghosh, 2012). Both pathways can be activated by a variety of
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upstream signaling inputs that converge on the two common pathways. Signals
activating the canonical pathway lead to phosphorylation of the Inhibitor of nuclear
factor κB kinase subunit β (IKKβ), which in turn phosphorylates the nuclear factor of
kappa light polypeptide gene enhancer in B-cells inhibitor, alpha (IκBα) (Hayden and
Ghosh, 2012). IKKβ normally exists in complex with IKKα and the NF-κB essential
modulator (Nemo), and Nemo expression is absolutely required for IKKβ
phosphorylation of IκBα and activation of the canonical pathway (Li et al., 1999;
Rudolph et al., 2000). IκBα normally binds to NF-κB factor complexes (RelA/p50 most
commonly) and prevents their activity; upon phosphorylation it is degraded and
RelA/p50 (or other) complexes are free to activate transcription of target genes (Hayden
and Ghosh, 2012).
The non-canonical pathway follows a somewhat similar sequence of events
requiring different factors. Initial activation depends on stabilization and accumulation
of the NF-kB inducing kinase (NIK), and so non-canonical signaling acts relatively slowly
as it requires new protein synthesis (Senftleben et al., 2001). NIK phosphorylates IKKα,
which in turn phosphorylates p100. Prior to phosphorylation, p100 exists in
transcriptionally inactive complex with RelB; upon phosphorylation p100 undergoes
partial proteolytic processing to the active p52 form. The p52/RelB dimer can then
activate transcription of target genes (Hayden and Ghosh, 2012).

21

Although both the canonical and non-canonical pathways typically activate gene
transcription, NF-κB factors can also inhibit transcription of target genes in some
circumstances. For example p50/p50 or p52/p52 homodimers, lacking transactivation
domains, can prevent the binding of activating NF-κB complexes (Bohuslav et al., 1998).
Cofactors such as Bcl-3 can modify the activity of p50/p50 and p52/p52 homodimers;
complexes containing Bcl-3 can either activate or inhibit transcriptional activation,
depending on post-translational modifications of the Bcl3 protein (Fujita et al., 1993;
Dechend et al., 1999; Grundström et al., 2004).
Although there are several NF-κB binding sites within the Rag gene locus
(Verkoczy et al., 2005), the role of NF-κB signaling in regulating Rag expression has been
controversial; various studies find that NF-κB activity either promotes, represses, or has
no effect on Rag1 and Rag2 mRNA expression. Studies showing no effect of NF-κB on
Rag1 and Rag2 expression focused on basal expression in pre-B cells, showing that
neither Nemo-deficiency nor expression of a dominant-negative IκBα construct affected
Rag1 or Rag2 mRNA expression (Amin and Schlissel, 2008; Derudder et al., 2009). An
earlier study implicated NF-κB in promoting Rag1 and Rag2 expression during receptor
editing in immature B cells (Verkoczy et al., 2005). This study showed that IgMcrosslinking relieved IκBα-mediated NF-κB inhibition and caused several NF-κB factors to
bind the Rag gene locus. However, the same study showed that p50 knock-out pre-B
cells have constitutively high levels of Rag1 and Rag2 mRNA, suggesting that this factor
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normally suppresses Rag1 and Rag2 expression. More recently, IKK inhibition was
shown to modestly increase recombination of a reporter substrate in cycling Abelson
cells without sti-571 treatment, suggesting that NF-κB activity normally suppresses Rag1
and Rag2 expression (Ochodnicka-Mackovicova et al., 2015).
Roles of the DNA damage response in V(D)J recombination
The DSBs produced during V(D)J recombination activate the conserved DNA
damage response (DDR), and the signals generated by this pathway are crucial for
proper recombination and for normal lymphocyte development (Bredemeyer et al.,
2006; Huang et al., 2007; Bredemeyer et al., 2008). The protein kinase ATM plays an
important role in this response. ATM is activated by DSBs and coordinates a variety of
downstream signals promote DSB repair, arrest the cell cycle to allow time for repair,
and promote apoptosis if the DSBs cannot be repaired (Shiloh and Ziv, 2013). Due to
these crucial functions, humans and mice deficient in ATM expression are predisposed
to develop a genomic instability leading to cancer (Barlow et al., 1996; Taylor et al.,
1996; Xu et al., 1996). In pre-B cells, ATM regulates the expression of many genes
important for B cell development, implicating the DDR in developmental processes
besides V(D)J recombination (Bredemeyer et al., 2008). Although V(D)J recombination
can occur without ATM, ATM is normally activated by RAG-mediated DSBs and is
required for their efficient and accurate repair (Bredemeyer et al., 2006). Additionally,
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the Bassing laboratory has shown that ATM can mediate feedback inhibition of V(D)J
recombination, ensuring that only one antigen receptor gene rearranges at a time
(Steinel et al., 2013).
Although it is crucial for lymphocyte development, the deliberate formation of
DSBs during V(D)J recombination creates a risk of translocation if the process goes awry.
RAG-mediated DNA cleavage would be particularly risky in the presence of existing DNA
damage, as the presence of two DSBs in a cell increases the risk of translocation by
several orders of magnitude (Richardson and Jasin, 2000). Normal cellular metabolism,
environmental factors, or off-target activity of RAG itself at cryptic RSSs could all create
DSBs with the potential to translocate with cleaved antigen receptor loci. Translocations
of antigen receptor loci pose a particular oncogenic risk as they contain enhancers and
promoters that are highly active in developing lymphocytes, which if translocated could
drive the expression of a proto-oncogene. Indeed, many lymphoid cancers in humans
and in mouse models involve clonal AgR translocations that are believed to promote
oncogenesis (Leder et al., 1983; Schlissel, 2006). In this context, it is plausible that a
developing lymphocyte might avoid creating a DSB at an antigen receptor locus when a
DSB already exists at another location in the genome.
Indeed, we find that DSBs suppress RAG expression and V(D)J recombination;
this central finding is discussed in Chapter 2. Chapter 3 focuses on the signaling events
24

necessary for this suppression. Chapters 2 and 3 focus on how exogenous sources of
DNA damage suppress RAG expression and V(D)J recombination. However, V(D)J
recombination itself requires DNA damage, and in this context suppression of RAG
expression can be considered a negative feedback loop. Chapter 4 discusses how
defects in this feedback loop can increase allelic inclusion in lymphocytes. Collectively,
these results suggest that developing lymphocytes employ a conserved pathway to react
to a programmed developmental stimulus (RAG-mediated DSBs) and non-programmed
stimulus (exogenous DSBs). While the regulation of RAG expression by developmental
cues has been well studied, this work shows that RAG expression can also be regulated
by external factors.
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Figure 1.1

Figure 1.1: Schematic of V(D)J recombination. (A) Germline antigen receptor antigen
receptor locus. Rag cleaves recombination signal sequences adjacent to D and J
segments, creating a DJ join. (B) In a second round of RAG activity, a V segment
rearranges to the DJ segment to create (C) a complete VDJ rearrangement.
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Figure 1.2

Figure 1.2: Overview of lymphocyte development. B and T lineages diverge from a
common progenitor and undergo recombination of specific antigen receptor loci at
defined developmental stages. Background shading represents high Rag expression
(dark areas) or low Rag expression (light areas) at each developmental stage.
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Figure 1.3

Figure 1.3: Diagram of Rag1 and Rag2 genes and associated regulatory elements. The
grid shows proteins known to bind each element. "B" indicates binding in developing B
cells, "T" indicates binding in developing T cells, "DN T" indicates binding only in CD4CD8- thymocytes. "CLP" indicates binding in the common lymphoid progenitor. The
factors that regulate Rag1 and Rag2 transcription are largely distinct between B and T
cells. Sources: 1 (Fuller and Storb, 1997); 2 (Hsu et al., 2003); 3 (Novak et al., 2010); 4
(Borghesi et al., 2005); 5 (Reynaud et al., 2008); 6 (Wei et al., 2005); 7 (Amin and Schlissel,
2008); 8 (Dengler et al., 2008); 9 (Herzog et al., 2008); 10 (Hu et al., 2006); 11 (Lauring and
Schlissel, 1999); 12 (Kishi et al., 2000); 13 (Miranda et al., 2002); 14 (Lee et al., 2013); 15
(Schulz et al., 2012); 16 (Verkoczy et al., 2005); 17 (Kishi, 2002); 18 (Fong et al., 2000); 19
(Wang et al., 2000); 20 (Brown et al., 1997); 21 (Jin et al., 2002); 22 (Okamura et al., 1998);
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(Wei et al., 2002); 24 (Yannoutsos et al., 2004) 2004; 25 (Hao et al., 2015); 26 (Reed et
al., 2013); 27 (Patra et al., 2006). Adapted and updated from (Kuo and Schlissel, 2009)
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Chapter 2: DSBs suppress Rag1 and Rag2 expression and V(D)J
recombination 1
Abstract
Developing lymphocytes must rearrange the genomic sequence of appropriate
antigen receptor genes by V(D)J recombination. The lymphocyte-specific endonuclease
RAG, composed of Rag1 and Rag2, initiates this process by cleaving specific sites within
antigen receptor loci. RAG expression is regulated to ensure that V(D)J recombination
occurs only under appropriate circumstances. The Bassing laboratory previously
demonstrated that RAG-mediated DNA cleavage in pre-B cells initiates a feedbackinhibition signal suppressing RAG expression. Here, we show that non-RAG mediated
DNA double strand breaks (DSBs) have a similar effect in suppressing mRNA expression
of Rag1 and Rag2. This effect can be observed in pro-B cells, pre-B cells, and DN
thymocytes, but not in DP thymocytes. In pre-B cells, loss of Rag1 and Rag2 mRNA
expression leads to loss of Rag1 protein, but Rag2 protein level is unaffected due to high
protein stability. Suppression of Rag1 expression by DSBs is associated with suppressed
RAG-mediated cleavage of the Igκ locus or an artificial recombination substrate in
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Abelson-transformed pre-B cells. However, simply over-expressing Rag1 does not allow
cells to complete V(D)J recombination in the presence of DSBs, suggesting that other
factors may also play a role in suppressing V(D)J recombination.

Introduction
Adaptive immunity requires the production of lymphocytes capable of
recognizing a broad and often unpredictable array of potential foreign antigens. In
jawed vertebrates, B and T lymphocytes achieve the necessary diversity of antigen
receptors by V(D)J recombination (Tonegawa, 1983). In this process, the Rag1/Rag2
endonuclease (RAG) makes paired DNA double strand breaks (DSBs) at recombination
signal sequences (RSSs) adjacent to variable (V), diversity (D), or joining (J) gene
segments within a selected antigen receptor locus; intervening DNA is either deleted or
inverted, and the DSBs are repaired by ubiquitous Non-Homologous End Joining (NHEJ)
factors (Helmink and Sleckman, 2012). The combination of V, D, and J segments, the
semi-random addition and removal of a limited number of nucleotides at the
breakpoints, and the use of two independently rearranged antigen receptor chains in
each receptor all contribute to the receptor diversity generated by V(D)J recombination
(Tonegawa, 1983).
V(D)J recombination is absolutely required for B and T cell development, as
failure to rearrange a complete antigen receptor leads to death of progenitor
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lymphocytes (Miosge and Goodnow, 2005). At each stage, the expression of the V(D)J
catalyst (RAG) and the accessibility of the substrate (antigen receptor genes) are both
regulated to ensure that the appropriate genes are rearranged at the appropriate time
(Vettermann and Schlissel, 2010). Antigen receptor genes are prepared for
rearrangement in the appropriate developmental stage by a process of histone
modification, precise nucleosome positioning, and DNA-looping to bring distant gene
segments into close proximity (Stanhope-Baker et al., 1996; Mandal et al., 2015; Hu et
al., 2015). Furthermore, expression of the RAG endonuclease is restricted to certain
stages of B and T cell development. Developing B cells first rearrange the
immunoglobulin heavy chain (IgH) chain locus as pro-B cells, and expression of a
functional IgH allele suppresses RAG expression and promotes progression to the pre-B
cell stage (Übelhart et al., 2015). After a series of cell divisions at the large pre-B1 stage,
re-expression of RAG in small resting pre-B2 cells allows light chain rearrangement and
expression of a complete B cell receptor (BCR) . Developing αβT cells go through a
similar process in which rearrangement of the TCRβ gene in DN thymocytes leads to
progression to the DP thymocyte stage and rearrangement of the TCRα gene (Miosge
and Goodnow, 2005).
Different transcription factors and genetic regulatory elements drive Rag1 and
Rag2 expression in developing B and T cells. For example, the Erag enhancer promotes
Rag1 and Rag2 transcription in both pro- and pre-B cells, but does not seem to affect
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expression in developing T cells (Hsu et al., 2003). Conversely, interplay between a
silencer and anti-silencer element control Rag1 and Rag2 expression in DP thymocytes
cells, but this system is only partially responsible for Rag1 and Rag2 transcription in DN
thymocytes, and not at all necessary in developing B cells (Yannoutsos et al., 2004).
However in both developing B and T cells, key developmental events either promote or
suppress RAG expression; for example, cell surface expression of a functional, nonautoreactive antigen receptor chain suppresses RAG expression in both developing B
and T cells (Turka et al., 1991; Li et al., 1993; Verkoczy et al., 2007). Such regulation
ensures that V(D)J recombination does not happen at inappropriate developmental
stages.
Although crucial for lymphocyte development, the deliberate formation of DSBs
during V(D)J recombination creates a risk of translocation if the process goes awry.
Richardson et al. show that co-existence of two DSBs at two different loci increases the
risk of translocation between those loci by several orders of magnitude (Richardson and
Jasin, 2000); therefore RAG-mediated DNA cleavage of an antigen receptor gene pose a
risk of translocation if another DSB already exists in the cell. Normal cellular
metabolism, genotoxic environmental factors, or off-target activity of RAG itself at sites
that mimic RSSs (cryptic RSSs) could all create DSBs with the potential to translocate
with antigen receptor loci cleaved by RAG (Schlissel, 2006). Translocations of antigen
receptor loci pose a particular oncogenic risk as their enhancers and promoters are
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highly active in developing lymphocytes and could drive the expression of a protooncogene if translocated. Indeed, many lymphoid cancers in humans and in mouse
models involve clonal antigen receptor translocations that are believed to promote
oncogenesis (Küppers and Dalla-Favera, 2001).
To combat the risks of DNA-double strand breaks, eukaryotic cells including
lymphocytes employ conserved DNA damage response (DDR) mechanisms. DSBs
activate the Ataxia Telangiectasia mutated (ATM) protein, which serves as the key
regulator of cellular responses to DSBs by phosphorylating a variety of substrates
leading to cell cycle arrest and DSB repair (Shiloh and Ziv, 2013). Lack of ATM function
allows genomic instability, and both humans and mice deficient for ATM are susceptible
to leukemias and lymphomas (Barlow et al., 1996; Taylor et al., 1996). Several studies
have demonstrated that RAG-induced DSBs in developing lymphocytes activate ATM
and downstream DDR pathways (Bredemeyer et al., 2008). In this context, ATM
promotes efficient repair of RAG-induced DSBs (Bredemeyer et al., 2006; Huang et al.,
2007). Previous work in the Bassing laboratory has demonstrated that ATM activation by
RAG-mediated DSBs can also suppress the induction of RAG-mediated DSBs in pre-B
cells. Specifically, RAG-induced DSB on one Igκ allele in pre-B cells suppresses RAG
mRNA and protein expression and prevents cleavage of the second Igκ allele in an ATMdependent manner (Steinel et al., 2013).
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As discussed above, the co-existence of multiple DSBs in a cell seriously increases
the risk of translocation. Given the need to prevent antigen receptor translocations
during V(D)J recombination, we hypothesized that exogenously-induced DSBs would
suppress RAG expression and function, just as RAG-mediated DSBs do. We find that
etoposide-induced DSBs suppress RAG expression and V(D)J recombination in pre-B cell
lines. Exposure to ionizing radiation (IR) to induce DSBs suppresses Rag1 and Rag2
mRNA expression in pro- and pre-B cells and in DN thymocytes, but not in DP
thymocytes. We discuss the possibility that suppression of RAG expression and activity
protects genomic stability of developing lymphocytes by preventing RAG-mediated
antigen receptor locus cleavage in the presence of another DSB that could promote
translocation.

Results
DSBs in pre-B cells suppress Rag1 and Rag2 mRNA expression
The Bassing laboratory has previously shown that RAG-mediated DSBs in pre-B
cells activate the DNA-damage response protein ATM to suppress Rag1 and Rag2 mRNA
expression and inhibit further RAG activity (Steinel et al., 2013). We hypothesized that
exogenously-induced DNA damage would share this suppressive effect on RAG
expression and V(D)J recombination in pre-B cells. To test this we used the two model

34

systems previously used to demonstrate the suppressive effect of RAG-mediated breaks:
IL-7 withdrawn ex vivo pre-B cells, and Abelson-transformed pre-B cell lines.
EμBCL2 primary pre-B cells can be grown for several days ex vivo with IL-7 to
expand the pre-B cell pool, and then withdrawn from IL-7 to induce RAG expression and
V(D)J recombination (Ray et al., 1998). This Bcl2 transgene is expressed in B and T
lineage cells and allows these cells to survive in culture and protects cells from apoptosis
upon exposure to DNA damage (Strasser et al., 1991a, 1991b). To determine the effect
of non-RAG mediated DSBs on pre-B cells, we exposed these cells to 4 Gy ionizing
radiation (IR). As a control to show that the cells experienced a DNA damage response,
we measured the induction of p21 mRNA caused by IR; we found that exposure to IR or
other DNA damaging agents caused the expected increase in p21 mRNA expression in all
cases (Fig. 2.1a,c,d). From one hour through four hours after IR exposure, Rag1 and
Rag2 mRNA expression in ex vivo pre-B cells decreased by approximately 80%. By 8
hours after IR exposure, Rag1 and Rag2 expression in these cells recovered to normal
levels (Fig. 2.1a). To rule out any role for RAG-induced DNA breaks in this response, we
turned to Abelson-transformed pre-B cell lines pre-treated with sti571 to induce Rag1
and Rag2 expression (Muljo and Schlissel, 2003). We compared the effect of IR on wildtype Abelson cells and Abelson cells expressing a cleavage-incompetent Rag1 mutant
protein (Rag1D708A). We found that both wild-type and Rag1D708A cells suppressed Rag1
and Rag2 mRNA expression in response to IR, although the response was slower than in
35

primary cells (Fig. 2.1b). These results show that IR can suppress Rag1 and Rag2
expression without any contribution from RAG-mediated DSBs.
These results suggest that exogenously induced DSBs can suppress Rag1 and
Rag2 expression. However, IR causes many kinds of cellular damage in addition to DSBs.
To more specifically test the effect of DSBs, we tested the effect of two genotoxic drugs
on Rag1 and Rag2 expression in IL-7 withdrawn pre-B cells. The drug etoposide poisons
type II topoisomerase and prevents them from religating the DNA strands (Montecucco
et al., 2015). Bleomycin induces DSBs, but may also damage RNA (Hecht, 2000).
Exposure to 10μg/mL etoposide leads to a rapid decrease in Rag1 and Rag2 mRNA
expression by approximately 90% (Fig. 2.1c). Similarly, exposure to 5μM bleomycin leads
to an approximately 75% decrease in Rag1 and Rag2 mRNA expression (Fig. 2.1d).
Collectively, these results show that the DSB response in pre-B cells involves turning off
Rag1 and Rag2 expression.
DSBs suppress Rag1 and Rag2 expression in bone marrow and thymus.
Rag1 and Rag2 are expressed at defined stages of B and T cell development, and
different transcription factors and genetic elements regulate its expression in different
cell types (Hsu et al., 2003; Yannoutsos et al., 2004). Because of this heterogeneity, we
decided to test whether the effect of DNA damage was specific to pre-B cells, or shared
by other RAG-expressing lymphocytes. To survey the effect of DSBs on a variety of
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developing lymphocyte populations, we exposed live EμBCL2 mice to 10Gy IR. The Bcl-2
transgene is expressed in both B and T lineage cells in these mice (Strasser et al., 1991a).
We then isolated bone marrow (BM) or thymocytes from irradiated mice 1 or 4 hours
after IR, and from unirradiated control mice to measure Rag1 and Rag2 mRNA levels by
qPCR. As a control to show that the cells experienced a DNA damage response, we
measured the induction of p21 mRNA caused by IR. Upon IR, we found that Rag1
expression in EμBCL2 BM decreases by approximately 75%, while Rag2 expression
decreases by approximately 60%. (Fig. 2.2a). To demonstrate that this response is not
somehow caused by the EμBCL2 transgene we performed a similar experiment using
wild-type mice. BM from wild-type mice suppressed Rag1 and Rag2 expression by
approximately 90% in response to IR (Fig. 2.2c). In contrast, IR exposure does not
suppress Rag1 or Rag2 mRNA expression in EμBCL2 thymocytes, and may even lead to
increased expression (Fig. 2.2b). We found a similar effect using wild-type thymocytes
(Fig. 2.2d). In bone marrow of wild-type or EμBCL2 mice, most RAG-expressing are pre-B
or immature B cells, relatively late developmental stages. Similarly, Rag-expressing cells
in the thymus consist largely of DP thymocytes, the T cell developmental stage
analogous to the pre-B cell stage. Therefore, these results likely reflect the response of
pre-B cells and pre-T cells to DSBs, while the effect on pro-B cells ad pro-T cells is
masked by their relatively low numbers.
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DSBs suppress Rag1 and Rag2 expression in early stages of B and T cell development
To determine the effect of IR on Rag1 and Rag2 mRNA expression at earlier
stages of B and T cell development, we repeated the experiments above using Rag2-/and Rag1-/- mice. In these mice, B cell development is arrested at the pro-B cell stage,
and T cell development is arrested at the DN thymocyte stage (Hao and Rajewsky, 2001;
Mombaerts et al., 1992a). Therefore, in a Rag-deficient mouse, the Rag-expressing cells
in the BM consist largely of pro-B cells and earlier precursors, while Rag-expressing cells
in the thymus consist of DN thymocytes. Again, increased p21 expression indicated that
these tissues experienced DNA damage (Fig 2.3a-d). Rag1 expression in both the BM of
Rag2-/- mice decreases approximately 80% upon exposure to 10Gy IR (Fig. 2.3a);
similarly, Rag2 expression in BM of Rag1-/- mice decreases upon exposure to IR (Fig.
2.3b). Interestingly, IR caused an approximately 50% decrease in Rag1 expression in
Rag2-/- thymocytes (Fig. 2.3c), and a similar decrease in Rag2 expression in Rag1-/thymocytes (Fig2.3d). Although less robust than the effect in BM, this suppression is
strikingly different from the modest induction of Rag1 and Rag2 upon exposure of wildtype thymocytes to IR. Therefore, we conclude that DSBs can suppress Rag1 and Rag2
expression at early stages of both B and T cell development; this ability persists in B cells
through the pre-B cell stage, but is lost in T cells as they develop to the DP stage. These
findings are consistent with the fact that regulation of basal Rag1 and Rag2 mRNA
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expression in developing B and T cells is relies on different genetic elements and
transcription factors, as discussed in Chapter 1.
DSBs suppress Rag1 but not Rag2 protein levels
The previously reported half-lives of both Rag1 and Rag2 half-life are very short,
from 10-30 minutes (Grawunder et al., 1996; Lin and Desiderio, 1993; OchodnickaMackovicova et al., 2015). Therefore, we expected the expression of both proteins to
decrease rapidly as their mRNA expression was suppressed after IR. However, when we
measured protein expression in irradiated IL-7 withdrawn pre-B cells, we unexpectedly
found that only Rag1 protein levels decreased within the timecourse of these
experiments; Rag2 protein levels remained consistent for several hours after induction
of DNA damage by etoposide or IR (Fig. 2.4a&b). The persistence of Rag2 protein
expression in the absence of its mRNA suggests that the protein is more stable than
previously reported (Lin and Desiderio, 1993). This seemed particularly plausible as the
half-life of wild-type Rag2 has only been reported using asynchronously dividing cell
lines, and Rag2 is known to be degraded at the G1/S checkpoint (Li et al., 1996).
The half-life of Rag2 is immeasurably long
To measure the half-life of Rag2 protein in G1-arrested cells capable of carrying
out V(D)J recombination, we treated IL-7 withdrawn pre-B cells with the ribosome
inhibitor cycloheximide (CHX) and quantified Rag2 levels after treatment. We could not
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detect a decrease in Rag2 levels earlier than 24 hours after CHX addition, at which point
the cells began to die from the treatment (Fig. 2.4c&d). We also measured expression of
the short-lived c-myc protein to confirm that the CHX treatment effectively stopped new
protein translation. c-myc protein was rapidly depleted by CHX treatment (Fig. 2.4c&d).
These results show that the Rag2 protein is remarkably stable, explaining the persistent
Rag2 protein expression in the absence of Rag2 mRNA. In contrast, Rag1 protein levels
decrease similarly to Rag1 mRNA levels. This may be because Rag1 protein is
intrinsically less stable than Rag2. Alternatively, IR may induce degradation of existing
Rag1 protein in addition to preventing new protein synthesis by suppressing Rag1
mRNA expression. In either case, transcriptional suppression of both Rag1 and Rag2 has
a rapid effect on the abundance only of Rag1 protein. While both Rag1 and Rag2 are
absolutely required for RAG cleavage activity, Rag1 is normally present at much lower
levels than Rag2 in developing lymphocytes (Zhang et al., 2015). Therefore, modulating
Rag1 expression might be a more sensitive way to regulate cleavage activity than Rag2
expression.
DSBs inhibit RAG-mediated cleavage of the Igκ allele.
To determine whether suppression of Rag1 and Rag2 mRNA expression was
associated with inability to initiate V(D)J recombination, we treated an Artemis-deficient
Abelson pre-B cell line with the DSB-inducing agent etoposide. Upon addition of the v40

abl inhibitor sti571, these cells arrest in the G1 cell cycle stage, induce Rag expression,
and cleave the Igκ locus (Muljo and Schlissel, 2003). Artemis-deficient cells cannot repair
RAG-mediated DSBs, so the accumulation of these breaks can be measured by Southern
blotting. Etoposide was added to the cells after 24-hours of pretreatment with sti571.
Consistent with the results of short-term DSB exposure in primary cells, exposure to
etoposide in these experiments suppressed Rag1 and Rag2 mRNA expression and
induced p21 mRNA expression (Fig. 2.5a). Furthermore, addition of etoposide halted the
accumulation of cleaved Igκ loci, while untreated cells continued to accumulate cleaved
loci over the following 24 hours (Fig 2.5b). We found the same suppressive effect on Rag
expression and Igκ cleavage by treating the cells with bleomycin instead of etoposide
(Fig. 2.5c&d).
Unfortunately, Rag1 and Rag2 protein expression in these cells is too low to
measure reliably by western blot. Therefore we could not definitively determine
whether Rag1 and Rag2 protein expression in Abelson cells exposed to etoposide or
bleomycin for long time periods follows the same pattern found in primary pre-B cells
exposed to IR, in which Rag1 protein decreases while Rag2 is maintained.
We repeated this experiment using an Artemis-sufficient Abelson cell line, to rule
out the possibility that abnormal repair of Rag-mediated DSBs in the absence of Artemis
causes the decrease in RAG activity. In this case, RAG makes breaks at Igκ loci which are
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rearranged in a variety of configurations, leading to loss of the germline Igκ band. Using
wild-type Abelson cells, we found that addition of etoposide prevents disappearance of
the germline Igκ band, indicating that V(D)J recombination is halted (Fig. 2.5f). As in the
Artemis-deficient lines, exposure to etoposide suppressed Rag1 and Rag2 mRNA
expression and induced p21 expression throughout the course of the experiment (Fig.
2.5e). These results show that exposure to DSBs prevents the RAG-mediated initiation of
V(D)J recombination in pre-B cells.
Suppression of V(D)J recombination is not specific to the Igκ locus.
In principle, V(D)J recombination can be regulated globally, for example by
manipulating factors like RAG necessary for recombination, or locally, for example
regulating accessibility of a specific antigen receptor locus to RAG. To determine
whether the inability of etoposide-treated pre-B cells to undergo V(D)J recombination
extends beyond the Igκ locus, we measured recombination of an artificial recombination
substrate (pMX-INV) in an etoposide-treated Abelson line (Gapud et al., 2011). This
substrate is chromosomally integrated, and therefore could be subject to broadly-acting
alterations in chromosome that could affect RAG activity. However, we do not expect it
to be specifically targeted in the way the Igκ locus could be. This substrate contains an
anti-sense GFP gene flanked by RSSs. RAG activity on this substrate inverts the GFP
gene, turning on GFP expression (Fig. 2.6a). We first treated these cells with sti-571 for
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24 hours. Within this time, Rag1 and Rag2 mRNA expression turned on, and
approximately 10% of the cells expressed GFP, indicating they had rearranged the
substrate (Fig. 2.6b&c). After 24 hours of sti-571 treatment, the culture was divided and
treated with either 10μg/mL etoposide or vehicle control. The control cell continued to
upregulate Rag1 mRNA expression, and the proportion of GFP+ cells increased to 40%.
In contrast, Rag1 and Rag2 expression decreased dramatically in etoposide-treated
cells, and the proportion of GFP+ cells remained at 10%, as it was at the time of
etoposide addition (Fig. 2.6b&c). We conclude that DSBs suppress V(D)J recombination
in general, and this effect does not require factors specific to the Igκ locus.
Enforced Rag1 expression does not restore the ability to complete V(D)J
recombination in the presence of DNA damage
Next, we tested the ability of Rag1-overexpression to overcome inhibition of
V(D)J recombination by DSBs. We tested the effects of Rag1 alone, because the
experiments shown in Fig. 2.4 show that Rag2 protein has a long halflife, so we do not
expect that its expression is affected by DSBs. We transfected pMX-INV+ cells with
retrovirus containing Rag1 cDNA or an empty vector. We then treated these cells as
described above, first with sti-571 for 24 hours, then adding etoposide or vehicle control
for an additional 48 hours. Empty-vector transduced cells behaved similarly to the
untransduced cells, in that etoposide treatment inhibited both Rag1 and Rag2
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expression and recombination of the artificial substrate (Fig. 2.6d&e). As expected, the
Rag1-transduced cells express far higher levels of Rag1 mRNA than vector-transduced
cells at all timepoints (Fig. 2.6d). Like in vector-transduced cells, Rag2 mRNA expression
is high in vehicle-treated cells and low in etoposide treated cells (Fig. 2.6d). Rag1
overexpression does not allow these cells to undergo pmx-INV recombination in the
presence of etoposide; among cells exposed to vehicle control the GFP+ cells increase
from 10% to 45% over 48 hours, while cells exposed to etoposide halt rearrangement
and remain approximately 10% GFP+ (Fig. 2.6e). We conclude that simply maintaining
Rag1 mRNA expression at a high level in the presence of etoposide does not prevent
inhibition of V(D)J recombination by DSBs.

Discussion
These studies show that DSBs caused by a variety of factors can suppress Rag1
and Rag2 mRNA expression in pre-B cells, leading to a loss of Rag1 protein. In vivo
studies suggest that this response is shared by pro- and pre-B cells, and to a lesser
extent DN thymocytes. However, we found no evidence that DSBs inhibit Rag1 or Rag2
expression in DP thymocytes. We found that exposure to DSBs prevented cleavage of
the Igκ locus and rearrangement of an artificial recombination substrate in pre-B cell
lines. However, this inhibition was not relieved by constitutive expression of Rag1
mRNA, suggesting that additional factors may play a role in inhibiting V(D)J
recombination in response to DSBs.
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The loss of Rag1 and Rag2 mRNA leads to selective loss of Rag1 protein, while
the relatively stable Rag2 protein persists in the absence of its mRNA. Both Rag1 and
Rag2 are absolutely required for RAG-mediated cleavage. At basal levels, Rag1 protein is
far less abundant than Rag2 protein (Zhang et al., 2015). Therefore Rag1 availability
might be a limiting factor and a more responsive target for regulating V(D)J
recombination activity.
The failure of constitutive Rag1 mRNA expression to restore V(D)J recombination
activity in the presence of etoposide suggests that additional signals beyond
suppression of Rag1 expression are involved. Possibilities include post-translational
modifications that inactivate any Rag1 protein that persists, or inactivating
modifications of Rag2 protein. Both Rag1 and Rag2 contain S/TQ motifs, the target
sequence for the ATM kinase and related PI3K-like kinases including DNA-PKcs (Gapud
et al., 2011). Indeed, DNA-PKcs can phosphorylate Rag2 in vitro (Hah et al., 2007).
Phosphorylation by other factors might also play a role. For example, the metabolic
sensor AMPK was shown to increase Rag1 cleavage activity by phosphorylating Rag1 on
amino acid S528 (Um et al., 2013); this might be prevented by DSB. Other post
translational modifications might also be affected, such as the autoubiquitylation of
Rag1 that normally increases its cleavage ability (Singh and Gellert, 2015).
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In fact there is already evidence that Rag2 is phosphorylated in the presence of
DSBs. Rodgers et al. have shown that a portion of the Rag2 protein pool is exported
from the nucleus following IR of Abelson-transformed pre-B cells (Rodgers et al., 2015).
The purpose of this export is unclear, particularly as over half of total Rag2 protein
remains nuclear. However, export was shown to require the cdk-phosphorylation site
T490, suggesting that at least some fraction of available Rag2 is phosphorylated at this
site following IR. Phosphorylation at T490 of Rag2 is normally associated with
degradation (Lin and Desiderio, 1993); however the persistent Rag2 expression
observed in our study and in the Rodgers study suggests that this is not the case in the
context of DSBs. Skp2-SCF, the E3 ligase implicated in Rag2 ubiquitylation after T490
phosphorylation, is poorly expressed in G1 phase until just before the G1/S transition
(Jiang et al., 2005; Bilodeau et al., 1999); therefore, T490 phosphorylation of Rag2 in G1arrested cells, like those used in our study, may lead to fates other than degradation.
Alternatively, Rag2 protein might be inactivated by post-translational modifications that
leave its expression intact.
Another potential method of suppressing RAG activity is to decrease the
accessibility of target antigen receptor loci. It was recently found that RAG-mediated
DSBs induce expression of the Ets-family member Spi-c, which competes with
transcriptionally active Ets family members for binding at the Igκ locus and decreases
Igκ accessibility and RAG-mediated cleavage (Bednarski et al., 2016). We also find
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induction of Spi-c mRNA expression in our recombination assays, although etoposide
treatment causes only a slight increase in Spi-c expression above the level induced by
RAG-mediated DSBs alone (discussed further in Chapter 4). However, the ability of
etoposide treatment to inhibit recombination of an artificial recombination substrate
suggests that locus-specific factors such as Spi-c are not required to inhibit
recombination, even if they do contribute to regulation of endogenous loci.
It is also possible that DSBs normally suppress V(D)J recombination by
suppressing Rag1 expression, but that details of our experimental setup account for the
failure of constitutive Rag1 mRNA expression to rescue. For example, the 48 hour DSB
exposure used in our experiments is far longer than the time normally required to repair
DSBs (Rothkamm et al., 2003). This long DSB exposure might have effects that would not
be relevant to a developing lymphocyte experiencing only normal levels of DSB
exposure. For example, Rag2 protein expression might decrease during this long time
course. We assume that Rag2 protein half-life is long in Abelson cells, as it is in primary
pre-B cells. However, we cannot directly measure this because basal expression of Rag2
in Abelson cells is much lower than in primary cells and cannot be reliably detected by
western blotting. Indeed, the fact that both Rag1 and Rag2 proteins have low expression
in Abelson cells but mRNA expression is comparable with primary cells suggests that 1)
translation of these mRNAs is lower in Abelson cells, or 2) the half-life of the proteins is
shorter. Therefore, it is possible that in the systems we used to measure V(D)J
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recombination, both Rag1 and Rag2 protein expression decreases in the presence of
DSBs, and that constitutive expression of both proteins would allow V(D)J
recombination activity in the presence of DSBs.
The differential regulation of Rag1 and Rag2 mRNA expression observed in
different lymphocyte subsets is not entirely surprising, as it has long been known that
different transcription factors and different enhancer elements drive basal Rag1 and
Rag2 expression in different kinds of lymphocytes. The Erag, Ep, and Ed enhancers are
all active in pro- and pre-B cells (Hsu et al., 2003; Wei et al., 2002, 2005). Erag is also
active in the common lymphoid progenitor (Borghesi et al., 2005). The Ed enhancer is
also active in DN thymocytes, but none of these three elements affect Rag1 or Rag2
expression in DP thymocytes. Instead, the ASE overcomes a highly active silencer
element to allow Rag1 and Rag2 expression in DP thymocytes; the ASE has some activity
in DN thymocytes, but none in pro- or pre-B cells (Yannoutsos et al., 2004). The pattern
of required enhancers is reminiscent of the pattern of Rag1 and Rag2 suppression by
DSBs: a strong effect in pro- and pre-B cells, which generally use the same regulatory
elements for Rag1 and Rag2; modest suppression in DN thymocytes, which uses one
enhancer element in common with developing B cells; and no suppression in DP
thymocytes, which uses an entirely different enhancer to regulate Rag1 and Rag2
transcription. While not conclusive, this pattern suggests that 1) DSBs suppress Rag1
and Rag2 mRNA expression by inhibiting their transcription, and 2) this regulation
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involves regulatory elements used by pro- and pre-B cells as well as DN thymocytes. The
Ed enhancer is the only identified element that fits this description; additional
involvement of the B cell-specific Erag and Ep enhancers might explain the more
effective suppression in pro- and pre-B cells. Additional experiments will be necessary to
determine whether these elements are the main targets of DSB signaling that lead to
the suppression of Rag1 and Rag2 expression.
Identification of critical genetic elements regulating Rag1 and Rag2 expression in
response to DSBs could allow us to mutate these elements and selectively abrogate this
response in in vivo developing lymphocytes. This would allow us to explore the role of
this response in lymphocyte development. As discussed in the introduction to this
chapter, we suggest that this signal plays a role in maintaining genomic stability by
preventing the creation of RAG-mediated DSBs at an antigen receptor locus while
another DSB exists that might lead to a translocation. Future experiments will attempt
to address this hypothesis by preventing the normal suppression of Rag1 and Rag2
expression during lymphocyte development in vivo, and measuring the frequency of
antigen receptor translocations and/or development of lymphoid malignancies. We also
have reason to believe that RAG-mediated DSBs activate the same signal to help prevent
simultaneous rearrangement of two antigen receptor alleles, enforcing allelic exclusion.
This effect will be discussed in Chapter 4.
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Figure 2.1

Figure 2.1: DSBs induced by a variety of agents suppress Rag1 and Rag2 mRNA
expression in pre-B cells. (A) qRT-PCR quantification of Rag1, Rag2, and p21 mRNA in
non-irradiated and irradiated EμBCL2 pre-B cells at indicated times after exposure to 4
Gy IR. Data are from 11 independent experiments. (B) qRT-PCR quantification of Rag1
and Rag2 mRNA expression in a wild-type Abelson cell line and a Rag1-mutant cell line
at indicted times after exposure to 4 Gy IR. Data are from 3 independent experiments.
(C) qRT-PCR quantification of Rag1, Rag2, and p21 mRNA in EμBCL2 pre-B cells at
indicated times after addition of 10 μg/mL etoposide to culture media. Data are from 3
independent experiments. (D) qRT-PCR quantification of Rag1, Rag2, and p21 mRNA in
EμBCL2 pre-B cells at indicated times after addition of 5 μM bleomycin to culture media.
Data are from 3 independent experiments. (A-D) Data are normalized to 1.0 for
untreated cells within each experiment. For treated cells, data averages are shown with
error bars indicating SEM. p-values calculated using Dunnett's post-test after ANOVA.
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Figure 2.2

Figure 2.2: DSBs suppress Rag1 and Rag2 mRNA expression in BM but not thymus. (A)
qRT-PCR quantification of Rag1, Rag2, and p21 mRNA in BM from non-irradiated EμBCL2
mice or EμBCL2 mice at indicated times after exposure to 10 Gy IR. Data are from one
experiment with 3-4 mice for each timepoint. (B) qRT-PCR quantification of Rag1, Rag2,
and p21 mRNA in thymuses from non-irradiated EμBCL2 mice or EμBCL2 mice at
indicated times after exposure to 10 Gy IR. Data are from three independent
experiments including a total of 4-6 mice per timepoint. (C) qRT-PCR quantification of
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Rag1, Rag2, and p21 mRNA in BM from non-irradiated wild-type mice at indicated times
after exposure to 10 Gy IR. Data are from two independent experiments including a
total of 4-5 mice per timepoint. (D) qRT-PCR quantification of Rag1, Rag2, and p21
mRNA in thymus from non-irradiated wild-type mice or wild-type mice at indicated
times after exposure to 10 Gy IR. Data are from two independent experiments including
a total of 4-5 mice per timepoint. (A-D) Data averages are shown with error bars
indicating SEM. p-values calculated using Dunnett's post-test after ANOVA.
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Figure 2.3

Figure 2.3: DSBs suppress Rag1 and Rag2 mRNA expression in both pro-B cells and pro-T
cells. (A) qRT-PCR quantification of Rag1 and p21 mRNA in BM from non-irradiated
Rag2-/- mice or Rag2-/- mice at indicated times after exposure to 10 Gy IR. Data are from
one experiment with 3 or 4 mice per timepoint. (B) qRT-PCR quantification of Rag2 and
p21 mRNA in BM from non-irradiated Rag1-/- mice or Rag1-/- mice at indicated times
after exposure to 10 Gy IR. Data are from three independent experiments with 4-6 mice
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per timepoint. (C) qRT-PCR quantification of Rag1 and p21 mRNA in thymus from nonirradiated Rag2-/- mice or Rag2-/- mice at indicated times after exposure to 10 Gy IR.
Data are from one experiment with 3 or 4 mice per timepoint. (D) qRT-PCR
quantification of Rag2 and p21 mRNA in thymus from non-irradiated Rag1-/- mice or
Rag1-/- mice at indicated times after exposure to 10 Gy IR. Data are from three
independent experiments with 4-6 mice per timepoint. (A-D) Data averages are shown
with error bars indicating SEM. p-values calculated using Dunnett's post-test after
ANOVA.
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Figure 2.4

Figure 2.4: Rag1 protein expression decreases after IR, but Rag2 protein is maintained.
(A) Representative western blot analysis depicting Rag1 and Rag2 protein in nonirradiated or irradiated EμBCL2 pre-B cells at indicated times after exposure to 4 Gy IR.
(B) Quantification of (A). Data are from 8 independent experiments. (C) Representative
western blot analysis depicting expression of Rag2 and c-Myc protein in cycloheximidetreated EμBCL2 pre-B cells. (D) Quantification of (C). Data are from 3 independent
experiments. (A-D) Data are normalized to 1.0 for untreated cells within each
experiment. For treated cells, data averages are shown with error bars indicating SEM.
p-values calculated using Dunnett's post-test after ANOVA.
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Figure 2.5
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Figure 2.5: DSBs inhibit V(D)J recombination in pre-B cells. (A) qRT-PCR quantification of
Rag1, Rag2, and p21 mRNA in Artemis-/- EμBCL2 Abl cells untreated or treated with
STI571 or STI571 and etoposide for the indicated amounts of time. Data are from 6
independent experiments. (B) Representative Southern blot analysis and graphical
quantification of Jκ cleavage in Artemis-/- EμBCL2 Abl cells treated with STI571 or STI571
and etoposide for the indicated amounts of time. Data are from 6 independent
experiments. (C) qRT-PCR quantification of Rag1, Rag2, and p21 mRNA in Artemis-/EμBCL2 Abl cells untreated or treated with STI571 or STI571 and bleomycin for the
indicated amounts of time. Data are from 3 independent experiments. (D)
Representative Southern blot analysis and graphical quantification of Jκ cleavage in
Artemis-/- EμBCL2 Abl cells treated with STI571 or STI571 and bleomycin for the
indicated amounts of time. Data are from 3 independent experiments. (E) qRT-PCR
quantification of Rag1, Rag2, and p21 mRNA in EμBCL2 Abl cells untreated or treated
with STI571 or STI571 and etoposide for the indicated amounts of time. Data are from 3
independent experiments. (F) Representative Southern analysis and graphical
quantification of Igκ recombination in EμBCL2 Abl cells untreated or treated with STI571
or STI571 and etoposide for the indicated amounts of time. Data are from 3
independent experiments. (A-F) Data averages are shown with error bars the SEM. pvalues were determined by Dunnett's post-test after ANOVA.
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Figure 2.6

Figure 2.6: DSBs inhibit recombination of an artificial recombination substrate, and
constitutive Rag1 expression does not overcome inhibition of recombination. (A)
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Schematic of the pMX-INV recombination substrate before and after RAG-mediated
recombination. (B) qRT-PCR quantification of Rag1, Rag2, and p21 mRNA in EμBCL2pINV Abl cells treated with STI571 or STI571 and etoposide for the indicated amounts of
time. Data are from 3 independent experiments. (C) Quantification of GFP+ cells among
hCD4+ EμBCL2-pINV Abl cells as determined by flow cytometry. Cells were treated with
STI571 or STI571 and etoposide for the indicated amounts of time. Data are from 3
independent experiments. (D) qRT-PCR quantification of Rag1, Rag2, and p21 mRNA in
EμBCL2-pINV Abl cells transduced with empty vector or retrovirus containing Rag1 and
treated with STI571 or STI571 and etoposide for the indicated amounts of time. Data are
from 3 independent experiments. (E) Quantification of GFP+ cells among hCD4+ EμBCL2pINV Abl cells as determined by flow cytometry. Cells were transduced with empty
vector or retrovirus containing Rag1 and treated with STI571 or STI571 and etoposide
for the indicated amounts of time. Data are from 3 independent experiments. (B-E) Data
averages are shown with error bars the SEM. p-values were determined by Dunnett's
post-test after ANOVA.
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Chapter 3: Signaling mechanisms leading to suppression of Rag1
and Rag2 expression by DSBs 1
Abstract
The work presented in Chapter 2 shows that DSBs induced by exogenous factors
can also suppress Rag1 and Rag2 mRNA expression and V(D)J recombination. Here, we
discuss the role of specific signaling pathways, particularly ATM and NF-κB, in
suppressing Rag1 and Rag2 mRNA expression. We find that suppression of Rag1 and
Rag2 mRNA expression is caused by rapid inhibition of Rag1 and Rag2 transcription.
This inhibition absolutely requires the activity of the ATM kinase. Inhibition is also
partially dependent on Nemo and IKKβ activity. Because suppression of Rag1 and Rag2
expression does not require new protein synthesis, we propose that the
ATM/Nemo/IKKβ signaling axis leads to post-translational modification of a
transcriptional regulator present in the cell before DSB exposure. Classically, the
ATM/Nemo/IKKβ pathway acts by activating NF-κB transcription factors; possible roles
for NF-κB factors in suppressing Rag1 and Rag2 transcription are discussed.

1
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Introduction
The regulation of basal Rag1 and Rag2 expression is complex; over a dozen
transcription factors have been implicated in some way in regulating Rag1 and Rag2
transcription (see Fig. 1.3). Most studies focus on factors that promote Rag1 and Rag2
transcription in the pro- and pre-lymphocytes expected to complete V(D)J
recombination, while a few studies examine the ways a functional antigen receptor
turns off Rag1 and Rag2 expression. One of the clearest findings is that B and T cells use
largely distinct mechanisms to turn Rag1/Rag2 transcription on and off, employing
lineage-specific transcription factors that act at different genomic regulatory
elements(Yu et al., 1999). This is particularly relevant, as we see that developing B cells
suppress Rag1 and Rag2 expression robustly in response to DSBs, while DN thymocytes
have a modest response and DP thymocytes do not suppress Rag1 and Rag2 in response
to DSBs.
In developing B cells, the forkhead-box protein Foxo1 is one of the most crucial
transcription factors promoting Rag1/Rag2 transcription (Amin and Schlissel, 2008;
Dengler et al., 2008). Several transcription factors necessary for Rag1 and Rag2
expression also promote Foxo1 expression, suggesting that their effect is at least
partially indirect; Ikaros and Bcl11a fall into this category (Lee et al., 2013; Reynaud et
al., 2008). Gfi1b, a negative regulator of Rag1/Rag2 transcription, also works partially by
suppressing Foxo1 expression (Schulz et al., 2012). Foxo1 binds to the Erag enhancer
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element, which is critical for Rag1 and Rag2 transcription in developing B cells (Hsu et
al., 2003; Dengler et al., 2008). Foxo1 activity is terminated by tonic signaling from a
functional antigen receptor that activates Akt to phosphorylate Foxo1 (Verkoczy et al.,
2007; Amin and Schlissel, 2008; Herzog et al., 2008).
Previous work from the Bassing laboratory implicated the DNA damage response
protein ATM in regulating Rag1 and Rag2 expression. Activation of ATM by DSBs
normally promotes repair and cell cycle arrest (Shiloh and Ziv, 2013). It was known that
RAG-mediated DSBs activate ATM, and that ATM activity is important for the efficient
repair of these breaks and for ensuring developing lymphocytes with cleaved antigen
receptor loci do not enter cell cycle (Bredemeyer et al., 2006; Callén et al., 2007; Dujka
et al., 2010).The Bassing laboratory showed that in addition to these functions, RAGinduced DSBs at the Igκ locus in pre-B cells suppress Rag1 and Rag2 expression.
Furthermore, ATM prevents pre-B cells from cleaving a second Igκ allele before the first
is repaired; this signal is believed to be important for normal allelic exclusion of Igκ
(Steinel et al., 2013).
Rag1 and Rag2 are by no means the only targets of ATM activation by RAGmediated cleavage of the Igκ locus; in fact, ATM activates hundreds of genes important
for genomic stability and lymphocyte development (Bredemeyer et al., 2008). Many of
these targets also require NF-κB activity (Bredemeyer et al., 2008; Bednarski et al.,
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2016). ATM can cooperate in activation of canonical NF-κB signaling by phosphorylating
the NF-κB essential modifier (Nemo) (Huang et al., 2003). In this context, activated ATM
and Nemo are exported from the nucleus and promote IKKβ activation and transcription
of NF-κB target genes (Huang et al., 2000; Verma, 2003). Interestingly, ATM can also
phosphorylate p65 to suppress transcription of a small subset of p65 target genes,
opposing the effect of activated Nemo on these genes (Sabatel et al., 2012).
DNA damage activates NF-κB signaling in many but not all cell and tissue types.
Notably, irradiation strongly activates NF-κB activity in bone marrow, but not in
thymocytes (Zhou et al., 1999). The mechanistic studies discussed in this chapter focus
on pre-B cells, as these cells can readily be cultured ex vivo. However, we believe that
similar mechanisms operate in pro-B cells and to some extent in DN thymocytes. In preB cells, we show that DSBs act through the ATM-Nemo signaling pathway to suppress
Rag1 and Rag2 transcription.

Results
DSBs inhibit Rag1 and Rag2 transcription, while mRNA turnover is mostly unaffected
In most identified cases, regulation of Rag1 and Rag2 mRNA occurs through
transcriptional regulation. However, steady state mRNA levels can be regulated either
by changes in input or outflow, ie either by changes in transcription or degradation.
Therefore, the decreased total mRNA levels upon DSBs exposure shown in Chapter 2
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could be caused either by decreased Rag1 and Rag2 transcription or increased
degradation of these mRNAs. To identify the mechanism by which DSBs suppress Rag1
and Rag2 expression, we measured turnover and transcription of these mRNAs in either
irradiated or unirradiated IL-7 withdrawn pre-B cells. For these experiments we used
Click-iT® technology, in which cells are cultured in media containing ethyl uridine (EU);
EU is incorporated into mRNA transcripts generated in its presence, and can be
specifically pulled down so that labeled RNA can be measured by qPCR.
To measure mRNA turnover, EU was added to the media of IL-7 withdrawn ex
vivo pre-B cells for 16 hours, and then washed out immediately before the cells were
either exposed to 4 Gy IR or left unexposed to IR. Loss of labeled transcripts over time
was measured by qPCR. Half-life was determined by normalizing the values measured
for labeled Rag1 and Rag2 mRNAs to labeled 18S RNA, which has a long half-life and
therefore undergoes negligible degradation within the timecourse of our assay. We
found that the half-life of both Rag1 and Rag2 mRNAs in unirradiated cells was about 40
minutes (Fig. 3.1a), similar to previously published results using nuclear run-on assays
(Verkoczy et al., 2005). IR did not change the half-life of Rag1 mRNA, while the half-life
of Rag2 mRNA decreased modestly, by approximately 25% (Fig. 3.1a). A 25% decrease in
Rag2 mRNA half-life is not sufficient to explain the rapid (<1hour) and substantial (80%)
decrease in total Rag2 mRNA measured in these circumstances (see figure 2.1a).
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To measure transcription, EU was added to the media of IL-7 withdrawn ex vivo
pre-B cells immediately after these cells were either exposed to 4Gy IR or left
unirradiated. The accumulation of new labeled transcripts was measured by qPCR and
normalized to values measured for EU-labeled Hprt, a transcript we do not expect to be
affected by IR. These data are presented as the ratio of new Rag1 or Rag2 transcripts in
irradiated vs. unirradiated transcripts; a ratio of 1 would indicate that IR has no effect on
transcription. As shown in Fig. 3.1b, by 45 minutes after irradiation irradiated cells have
produced significantly less new Rag1 and Rag2 mRNA than unirradiated cells, and a
trend in this direction can be observed as early as 30 minutes after irradiation. This
demonstrates a rapid and profound decrease in transcription of both the Rag1 and Rag2
genes following IR exposure. Therefore, we conclude that transcription is the major
mechanism through which DSBs suppress Rag1 and Rag2 mRNA expression, and
regulation of mRNA turnover does not play a major role.
Although these results show that Rag1 and Rag2 mRNA transcription is
profoundly reduced following IR of ex vivo cultured primary pre-B cells, it is formally
possible that this is not because Rag1 and Rag2 transcription is specifically targeted by
the DNA damage response (DDR), but rather because the extreme stress caused by
exposure to a high dose of IR leads to a general transcriptional repression of genes not
required for the DDR. One piece of evidence against this scenario is that the values for
newly transcribed Rag1 and Rag2 mRNA are normalized to newly transcribed Hprt
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mRNA; if all of these mRNAs were affected by a general transcriptional repression, then
there would be no apparent difference in the normalized values of irradiated and
unirradiated samples. Of course Hprt might be an exception, and so we also measured
transcription of another gene that is not required for the DDR, Wasp. We found that
irradiation caused a modest decrease in accumulation of new Wasp transcripts, but this
decrease was slower and much less profound than the decrease observed for Rag1 and
Rag2 transcripts (Fig. 3.1b). These data support our hypothesis that Rag1 and Rag2
expression is specifically targeted by the DDR in pre-B cells.
Suppression of Rag1 and Rag2 mRNA by DSBs does not require new protein synthesis
In broad terms, DSBs could suppress Rag1 and Rag2 transcription either by
increasing the expression and/or activity of a transcriptional repressor, or by decreasing
the expression and/or activity of a transcriptional activator. However, the speed with
which DSBs suppress Rag1 and Rag2 transcription suggests that the mechanism does
not require the synthesis of a new repressor, as this would be likely to act more slowly.
To test this directly, we treated IL-7 withdrawn and irradiated pre-B cells with
cycloheximide to determine whether new protein synthesis was required for
suppression of Rag1 and Rag2 transcription by DSBs. Cycloheximide treatment without
IR lead to an increase in Rag1 and Rag2 mRNA expression (Fig. 3.2a), as previously
reported (Verkoczy et al., 2005). However, cycloheximide treatment did not prevent the
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suppression of Rag1 and Rag2 mRNA expression by IR (Fig. 3.2a). This result indicates
that the suppressive signal acts through factors that are present in undamaged cells,
and does not require the synthesis of a new transcriptional inhibitor.
Suppression of Rag1 and Rag2 mRNA by DSBs does not require protein degradation
We next tested whether protein degradation was required for the suppression of
Rag1 and Rag2 mRNA expression by DSBs, as we would expect to be the case if the
signal depended on loss of a transcriptional activator. We find that suppression of Rag1
and Rag2 mRNA is unaffected by the proteosome inhibitor Mg132 (Fig. 3.2b). This
results shows that protein degradation is not absolutely required for inhibition of Rag1
and Rag2 transcription by DSBs. However, it is possible that the activity of a
transcriptional activator might be suppressed by post-translational modification rather
than by degradation.
ATM activity is required for suppression of Rag1 and Rag2 expression by DSBs
Having established general rules that the suppression of Rag1 and Rag2
expression by DSBs seems to follow, we investigated the involvement of specific
signaling pathways. Because RAG-mediated DSBs act through ATM to suppress Rag1 and
Rag2 mRNA expression (Steinel et al., 2013), we tested ATM's role in the response to IRinduced DSBs. We first determined the effect of ATM inhibition on DSB-mediated
suppression of Rag1 and Rag2 mRNA expression in ATM-sufficient IL-7 withdrawn
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primary pre-B cells. Either the ATM inhibitor KU55933 or vehicle control was added to
these cells at the same time as IL-7 withdrawal. 48 hours later, these cells were either
exposed to 4 Gy IR or left unirradiated. ATM inhibition led to increased basal Rag1 and
Rag2 mRNA expression in unirradiated cells. More importantly, ATM inhibition
completely prevented the suppression of Rag1 and Rag2 mRNA expression caused IR
(Fig. 3.3a). ATM inhibition also prevented the loss of Rag1 protein expression that
normally occurs after exposure to IR (Fig. 3.3b). To further confirm the role of ATM in
suppression of Rag1 and Rag2 mRNA expression, we exposed Mb1cre+ Atmf/f IL-7
withdrawn pre-B cells to 4 Gy IR and compared their Rag1 and Rag2 expression to
unirradiated controls. We found that IR exposure does not decrease Rag1 or Rag2
mRNA expression in ATM-deficient cells, in contrast to the suppression observed in
EμBCL+ ATM-sufficient cells. Collectively, these data show that DSBs act through the
DNA-damage response protein ATM to suppress Rag1 and Rag2 mRNA expression,
leading to decreased Rag1 protein expression.
Suppression of Gadd45α expression is not required to suppress Rag1 and Rag2 mRNA
expression
Previous work from the Bassing laboratory showed that RAG-mediated DSBs
suppress expression of Gadd45α mRNA and protein via ATM activity (Steinel et al.,
2013). Because other work showed that Gadd45α can indirectly regulate Rag1 and Rag2
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transcription by promoting activation Foxo1 activity (Amin and Schlissel, 2008), we
hypothesized that DSBs suppress Rag1 and Rag2 expression by decreasing Gadd45α
expression. However, we found that IR only modestly suppressed Gadd45α mRNA
expression, by about 50% (Sup. Fig. 3.1a). Furthermore, although Gadd45α transcription
was decreased by IR, this decrease occurred more slowly than the decrease in Rag1 and
Rag2 transcription (compare Fig. 3.2 and Sup. Fig. 3.1b). Finally, we performed several
experiments in which Gadd45α was constitutively expressed in a variety of conditions,
including using either an unmodified Gadd45α construct or a tamoxifen-inducible
version, and using either primary pre-B cells or Abelson-transformed pre-B cell line. Sup.
Fig. 3.1c shows the results of a representative experiment in which EμBCL2+ Abelson
cells were transduced either with empty vector or ER-Gadd45α. These cells were then
treated with tamoxifen and 2 hours later exposed to 4Gy IR or unexposed. In this
experiment, as in all conditions tested, we found that Gadd45α overexpression had no
effect on either basal Rag1 and Rag2 mRNA expression or in the suppression caused by
IR. Therefore, we believe that the decrease in Gadd45α expression caused by both RAGmediated and IR-induced DSBs is coincidental, and does not mediate suppression of RAG
expression.
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Activation of Nemo is required for optimal suppression of Rag1 and Rag2 by DSBs
Although ATM has many substrates and orchestrates a complex network of
responses to DSBs, two important branches of this signaling network act through p53
and Nemo (Miyamoto, 2011; Shiloh and Ziv, 2013). Therefore, we next investigated the
roles of p53 and Nemo in suppressing Rag1 and Rag2 expression following the induction
of DSBs in primary pre-B cells. To determine whether Nemo or p53 is required for
suppression of Rag1 and Rag2 expression by DSBs, we exposed cells deficient for each
factor to 4 Gy IR and compared their Rag1 and Rag2 mRNA expression to unirradiated
cells. We observed normal downregulation of Rag1 and Rag2 mRNAs following
irradiation of primary pre-B cells cultured from VavCre+Tp53flox/flox mice with
hematopoietic lineage-specific deletion of p53 (Sup. Fig. 3.2). In contrast, EμBCL+
Mb1cre+ Nemof/f IL-7 withdrawn pre-B cells did not suppress Rag1 and Rag2 mRNA
expression as efficiently as wild-type cells. Although Rag1 and Rag2 mRNA expression is
lower in irradiated Nemo-deficient cells than in unirradiated cells at 1 hour after
exposure, the decrease is less than that seen in Nemo-sufficient cells (Fig. 3.4a&b). By 4
hours after IR exposure, Rag1 and Rag2 mRNA expression in irradiated Nemo-deficient
cells recovers to normal levels, while expression in Nemo-sufficient cells is still repressed
this timepoint (compare Fig. 3.4a and Fig. 2.1a). The partial suppression observed 1 hour
after IR exposure suggests that a Nemo-independent mechanism may act very early to
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suppress Rag1 and Rag2 expression. However, Nemo is absolutely required for
sustained suppression of Rag1 and Rag2 mRNA expression by DSBs.
Activation of IKKα/β in pre-B cells exposed to IR
In most documented cases, Nemo regulates gene expression by allowing
activation of canonical NF-κB signaling pathway (Miyamoto, 2011). DNA damage has
been shown to activate NF-κB signaling in many cell and tissue types, including whole
bone marrow and pre-B cell lines (Zhou et al., 1999; Bredemeyer et al., 2008). One of
the hallmarks of NF-κB activation is phosphorylation of the key kinases IKKα (which
activates the non-canonical pathway) or IKKβ (which activates the canonical pathway).
To determine whether IL-7 withdrawn pre-B cells exposed to IR activate this pathway
within the timeframe that Rag1 and Rag2 expression are repressed, we measured
accumulation of phospho-IKK. The antibodies used bind both IKKα and IKKβ. Because
these two kinases have a similar molecular weight, we cannot distinguish between them
in this experiment. We found that phospho-IKKα/IKKβ accumulates as early as 30
minutes after IR exposure and persists for at least 60 minutes (Sup. Fig. 3.3). Notably,
phospho-IKKα/IKKβ is completely lost by 4 hours after IR exposure, although Rag1 and
Rag2 mRNA expression are still suppressed at this point (compare Sup. Fig. 3.3 and Fig.
2.1a). Therefore if NF-κB signaling is required for suppression of Rag1 and Rag2 mRNA
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expression, the suppressive effect can persist for some time after active signaling is
terminated.
Two IKK inhibitors have different effects on basal Rag1 and Rag2 expression and
response to DSBs.
As noted above, the most prominent role for Nemo in cell biology is through its
involvement in canonical NF-κB signaling. In the absence of Nemo, IKKβ is unable to
phosphorylate IκBα and activate NF-κB activity (Rudolph et al., 2000; Schröfelbauer et
al., 2012). Therefore, we hypothesized that lack of IKKβ activity would have a similar
effect on Rag1 and Rag2 mRNA expression as Nemo deficiency. We initially chose the
IKK inhibitor BMS-345541 because a recent paper showed that this inhibitor could act
synergistically with Akt inhibition to activate Rag1 mRNA expression in Abelsontransformed cells without sti571 treatment, a circumstance in which Rag1 expression is
normally strongly suppressed (Ochodnicka-Mackovicova et al., 2015). We first pretreated IL-7 withdrawn EμBCL2+ primary-pre-B cells with BMS-345541; after 2 hours the
culture was split and either exposed to 4 Gy IR or unirradiated. To our surprise, BMS345541 treatment alone inhibited Rag2 mRNA expression to approximately the same
extent as IR alone; there was no significant additional effect with combined BMS345541 treatment and IR (Fig. 3.5a). We also found a trend towards decreased Rag1
mRNA expression in the BMS-345541 treated cells (Fig. 3.5a). However whereas IR had a
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negligible effect on Rag2 expression in BMS-345541 treated cells, Rag1 expression
appeared to follow a pattern similar to that in Nemo-deficient cells, in which Rag1
expression first decreases modestly and then recovers to normal levels (compare Fig.
3.5a and Fig. 3.4a).
Notably, BMS-345541 inhibits IKKα as well as IKKβ, although the IC50 for IKKα
inhibition is approximately an order of magnitude greater (Burke et al., 2003).
Therefore, we considered that our results using BMS-345541 might be confounded by
inhibition of non-canonical NF-κB pathway in addition to the canonical pathway. To
address this issue, we repeated these experiments using the inhibitor ML120B, which
selectively inhibits IKKβ and has no effect on IKKα even at high doses (Nagashima et al.,
2006). In contrast to BMS-345541, treatment with ML120B caused a trend towards
increased Rag1 and Rag2 mRNA expression (Fig. 3.5b). When ML120B-treated pre-B
cells were exposed to IR, they experienced an early decrease in Rag1 and Rag2 mRNA
expression but began to recover by 4 hours after IR exposure; cells without the inhibitor
still showed strong suppression of Rag1 and Rag2 mRNA expression at this time point
(Fig. 3.5b). This is very similar to the effect of Nemo-deficiency, consistent with the
hypothesis that Nemo regulates Rag1 and Rag2 expression through its ability to
potentiate IKKβ activity.
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Nfkb1/p50 is not required for suppression of Rag1 and Rag1 mRNA by DSBs
Of the five NF-κB family transcription factors, only p50 has been specifically
shown to have any effect on Rag1 and Rag2 expression; p50 knockout pre-B cells have
approximately 3-fold higher Rag1 and Rag2 mRNA levels than wild-type cells (Verkoczy
et al., 2005). As this data suggests that p50 normally has a suppressive effect on Rag1
and Rag2 expression, we hypothesized that p50-deficient pre-B cells would be unable to
suppress Rag1 and Rag2 expression in response to DSBs. Because NF-κB signaling
normally promotes cell survival, we were concerned that the p50-deficient cells would
not survive the week-long culture used in most of our ex vivo pre-B cell experiments.
Therefore, we isolated total BM from Nfkb1-/- mice and pre-incubated them for only 2
hours before splitting the cells from each mouse into two pools, either unirradiated or
exposed to 4 Gy IR; RNA was collected from each pool 4 hours after IR exposure. Rag1
and Rag2 expression decreased in the p50-/- BM to a similar extent as in wild-type pre-B
cell cultures (Fig. 3.5c). We conclude that p50 is not required for normal suppression of
Rag1 and Rag2 mRNA expression in developing B cells.
LPS treatment suppresses Rag1 and Rag2 mRNA expression
The role of Nemo and IKKβ in suppressing Rag1 and Rag2 expression in response
to DSBs led us to wonder whether stimuli that activate NF-κB signaling independent of
ATM activity would also suppress Rag1 and Rag2 expression. To test this we exposed IL74

7 withdrawn pre-B cells to LPS, a potent inducer of NF-κB activity in pre-B cells (Sen and
Baltimore, 1986). LPS treatment suppressed Rag1 and Rag2 mRNA expression
approximately 80% within 4 hours of exposure. This is similar to the reduction caused by
IR, etoposide, or bleomycin. These results show that DSBs are not the only stimulus that
can suppress Rag1 and Rag2 expression, and are consistent with a central role for NF-κB
signaling in this pathway. However, both DSBs and LPS activate a multitude of
intracellular signaling pathways, and so additional work will be necessary to confirm the
importance of NF-κB factors in response to each stimulus.

Discussion
These studies show that suppression of Rag1 and Rag2 mRNA expression by
DSBs depends on rapid inhibition of Rag1 and Rag2 transcription. This inhibition
requires neither new protein synthesis nor protein degradation, suggesting that the
mechanism does not require production of a new transcriptional activator or
destruction of an existing transcriptional activator. We found that the DNA damage
response protein ATM is absolutely required for suppression of Rag1 and Rag2 mRNA
expression by DSBs. Nemo and IKKβ, upstream activators of canonical NF-κB signaling,
are also required for maximal suppression of Rag1 and Rag2 expression by DSBs.
However, the limited suppression observed in the absence of these factors suggests that
a second, more transient mechanism may also be involved in suppression of Rag1 and
Rag2 expression. Finally, the ability of LPS stimulation, like DSBs, to suppress Rag1 and
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Rag2 expression suggests that other stimuli can activate NF-κB signaling to suppress
Rag1 and Rag2 expression.
Several studies have implicated ATM in regulating V(D)J recombination to
promote mono-allelic rearrangement of antigen receptor alleles. Previous work from
the Bassing laboratory showed that RAG-mediated DSBs activate ATM and suppress
Rag1 and Rag2 expression (Steinel et al., 2013). The experiments presented in this
dissertation show that this signal is not unique to RAG-mediated DSBs, but rather can be
activated by DSBs induced by a variety of agents. This signal represents a highly cell-type
specific application of a ubiquitous DDR factor conserved from yeast to mammals,
highlighting the ability of evolution to employ ancient systems for new functions.
The Bassing laboratory previously showed that RAG-mediated DSBs suppress
expression of Gadd45α, a factor which had been shown to promote Rag1 and Rag2
expression by increasing Foxo1 activity (Amin and Schlissel, 2008; Steinel et al., 2013).
However, the work presented here does not support a role for Gadd45α in suppressing
Rag1 and Rag2 transcription. Gadd45α overexpression was not able to prevent
suppression of Rag1 and Rag2 expression; we found similar results when overexpressing Foxo1 (data not shown). Admittedly, these experiments cannot rule out the
possibility that post-translational modifications inhibit Gadd45α or Foxo1 activity;
indeed, it is well known that Foxo1 activity and stability in is inhibited through
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phosphorylation by Akt (Tzivion et al., 2011; Verkoczy et al., 2007; Amin and Schlissel,
2008). A recent study confirmed many of our central findings regarding the ability of
DSBs to suppress Rag1 and Rag2 expression via ATM activity in pre-B cell lines.
Additionally, this group found that DSBs lead to Foxo1 protein degradation and loss of
Foxo1 binding to the Erag enhancer in B-ALL cell lines (Ochodnicka-Mackovicova et al.,
2016). However, we find no decrease in Foxo1 protein or increase in Foxo1
phosphorylation in primary pre-B cells exposed to IR (data not shown). Although we
have not assayed Foxo1 binding to the Rag1/Rag2 gene locus, our data suggest that the
regulation of Foxo1 in primary pre-B cells does not completely recapitulate the
regulation found in B-ALL cell lines. However, it is possible ATM activates two diverging
pathways activating Nemo and inhibiting Foxo1 binding to the Rag1 and Rag2 locus, and
that both pathways contribute to optimal suppression of Rag1 and Rag2 expression.
This scenario could explain the limited suppression of Rag1 and Rag2 mRNA expression
we find in Nemo-deficient mice.
The effect of NF-κB activity on Rag1 and Rag2 expression has been controversial,
perhaps partially because of the complexity of NF-κB signaling itself. One widely-cited
study found IgM crosslinking in immature B cells increases Rag1 and Rag2 expression by
activating NF-κB factors. However, the same study found that Nfkb1 knockout cells have
increased Rag1 and Rag2 expression; the authors suggested that transcriptionally
inactive p50/p50 homodimers might compete with transcriptionally active p65 and c-Rel
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containing complexes (Verkoczy et al., 2005). Several studies find that DN IκBα, which
inhibits canonical NF-κB activation, has no effect on Rag1 and Rag2 expression in pre-B
cells (Amin and Schlissel, 2008; Cadera et al., 2009). On the other hand, inhibition of
IKKβ increased Rag1 expression in certain pre-B cell lines (Ochodnicka-Mackovicova et
al., 2015).
Here, we add to this confusing mess of data points by showing that Nemo and
IKKβ participate in suppressing Rag1 and Rag2 expression in pre-B cells exposed to
DSBs. Furthermore, we found that an IKKα/IKKβ inhibitor seriously impaired Rag2
expression but had little effect on basal Rag1 expression, a notable exception to the
general rule that expression of Rag1 and Rag2 mRNAs are coordinately regulated. In
contrast, an IKKβ-specific inhibitor does not suppress, and may even increase, Rag1 and
Rag2 mRNA expression. Although only specific NF-κB transcription factor tested,
Nfkb1/p50, was not required for suppression of Rag1 and Rag2, this does not rule out a
role for NF-κB signaling as other NF-κB factors are still active in these cells (Sha et al.,
1995).
Together, these results suggest several potential explanations for the confusion
in the literature. First, apparently contradictory findings might be due to the different
methods used to manipulate NF-κB, which affect different steps of NF-κB activation and
may have narrower or broader effects on the various NF-κB homo- and heterodimers
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and the IkB factors that regulate them. Indeed, our IKK inhibitor experiments suggest
that IKKα and IKKβ activity might have opposing effects on Rag1 and Rag2 expression.
Secondly, most of this activity seems to be induced by stimulus-induced, and may be
less important under normal conditions; this would explain the lack of effect previously
seen on basal Rag1 and Rag2 expression. Additionally, the expression of many NF-κB
factors and their regulatory proteins is known to change throughout B cell development,
particularly at the pre-B to immature B transition (Sup. Fig. 3.4 and Kistler et al., 1998).
This raises the possibility that NF-κB activity might have different effects on Rag1 and
Rag2 activity depending on the developmental stage of the cell.
Although the bulk of this our work focuses on the effect of DSBs on Rag1 and
Rag2 expression, the apparent involvement of NF-κB factors led us to question whether
other stimuli that activate NF-κB signaling would also suppress Rag1 and Rag2
expression in pre-B cells. Indeed, we find that exposure to the bacterial endotoxin LPS
suppresses Rag1 and Rag2 mRNA expression. LPS is an inflammatory stimulus, and it has
been thoroughly documented that inflammation suppresses B cell development at
multiple stages (Cain et al., 2009). It will be important to confirm that NF-κB factors play
a role in the suppression of Rag1 and Rag2 expression by LPS, and determine whether
other inflammatory stimuli have a similar effect. Interestingly, it was recently shown
that chronic inflammation can suppress Rag1 expression in the common lymphoid
progenitor, the earliest developmental stage in which it is normally expressed (Baratono
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et al., 2015). In itself, the ability of LPS to suppress Rag1 and Rag2 mRNA expression
simply tells us that DSBs are not unique in their ability to suppress Rag1 and Rag2
expression. Of course, these two stimuli are very different in nature. DSBs represent a
threat within the developing lymphocyte itself; as discussed in Chapter 2, initiation of
V(D)J recombination in the presence of DSBs might lead to oncogenic antigen receptor
translocations. LPS and other inflammatory stimuli do not necessarily represent a threat
to the health of an individual lymphocyte, but rather to the larger organism. Therefore
on a more speculative level, our results suggests that two quite different "danger"
stimuli activate a conserved pathway to suppress Rag1 and Rag2 expression in
situations where V(D)J recombination may be undesirable.
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Figure 3.1

Figure 3.1: DSBs cause a rapid and specific decrease in Rag1 and Rag2 transcription. (A)
qRT-PCR quantification of EU-labeled Rag1 and Rag2 mRNA levels relative to EU-labeled
18S RNA levels in non-irradiated or irradiated EμBCL2 pre-B cells at indicated times after
EU washout and/or exposure to 4 Gy of IR. Data are from 4 independent experiments.
Data averages are shown with error bars the SEM. Prism 5 was used to calculate best-fit
curves, half-lives and p-values. ***p<0.001. (B) qRT-PCR quantification of EU-labeled
Rag1, Rag2, and Wasp mRNA levels relative to EU-labeled Hprt mRNA levels in nonirradiated or irradiated EμBCL2 pre-B cells at indicated times after addition of EU and
exposure to 4 Gy of IR. Data are presented as the ratio of relative levels of each mRNA in
irradiated cells compared to non-irradiated cells. The gray line represents a value of 1,
which would indicate that IR had no effect on the transcription rate of a gene. Data are
from 4 independent experiments. p-values for whether the average ratio at each time
point is different from 1.0 was determined using one-tailed T test with Bonferroni's
correction for multiple testing.
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Figure 3.2

Figure 3.2: DSBs do not require new protein synthesis or protein degradation to
suppress Rag1 and Rag2 mRNA expression. (A) qRT-PCR quantification of Rag1 and
Rag2 mRNA in EμBCL2 pre-B cells treated with cycloheximide and then not irradiated
exposed to 4 Gy IR. Data are from 3 independent experiments. (B) qRT-PCR
quantification of Rag1 and Rag2 mRNA in EμBCL2 pre-B cells treated with mg132 or
vehicle control and non-irradiated or irradiated with 4 Gy IR at indicated times after
exposure IR. Data are from 3 independent experiments. (A&B) Data averages are shown
with error bars the SEM. p-values were calculated by T test with Bonferroni's correction
for multiple testing.
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Figure 3.3

Figure 3.3: ATM is required for DSBs induced in pre-B cells to downregulate Rag1 and
Rag2 expression. (A) qRT-PCR quantification of Rag1, Rag2, and p21 mRNA in nonirradiated or irradiated EμBCL2 pre-B cells at indicated times after exposure to 4 Gy of
IR. Cells were treated with 15 μM of the KU55933 ATM kinase inhibitor or vehicle
(DMSO) for 48 hours prior to irradiation or harvesting of non-irradiated cells. Data are
from 8 independent experiments. (B) Representative western blot and quantification
from experiment described in (A). (C) qRT-PCR quantification of Rag1, Rag2, and p21
mRNA in non-irradiated or irradiated Mb1Cre+Atmflox/flox pre-B cells at indicated times
after exposure to 4 Gy IR. Data are from 3 independent experiments. (A-C) Data are
normalized to 1.0 for non-irradiated cells harvested one hour following IR exposure of
irradiated samples. For other samples, data averages are shown with error bars
indicating SEM. p-values were calculated by Dunnett's post-test after ANOVA.
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Figure 3.4

Figure 3.4: Nemo is required for pre-B cells to normally downregulate Rag1 and Rag2
expression in response to DSBs. (A) qRT-PCR quantification of Rag1, Rag2, and p21
mRNA in non-irradiated Mb1Cre+Nemoflox/floxEμBCL2 pre-B cells or irradiated
Mb1Cre+Nemoflox/floxEμBCL2 pre-B cells at indicated times after exposure to 4 Gy IR. Data
are from 3 independent experiments. p-values were calculated by Dunnett's post-test
after ANOVA. (B) qRT-PCR quantification of Rag1 and Rag2 mRNA in non-irradiated or
irradiated pre-B cells from EμBCL2 or Mb1Cre+Nemoflox/floxEμBCL2 mice at 1 hour after
exposure to 4 Gy IR. Data are from 3 independent experiments. p-value was calculated
by T test. (A&B) Data are normalized to 1.0 for non-irradiated cells harvested one hour
following IR exposure of irradiated samples. For other samples, data averages are shown
with error bars indicating SEM.
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Figure 3.5

Figure 3.5: Variable effects of IKK inhibitors on basal Rag1 and Rag2 expression and on
suppression by DSBs. (A) qRT-PCR quantification of Rag1, Rag2, and p21 mRNA in nonirradiated or irradiated EμBCL2 pre-B cells at indicated times after exposure to 4 Gy of
IR. Cells were treated with 5 μM BMS-345541 IKK kinase inhibitor or vehicle (DMSO) for
2 hours prior to irradiation. Data are from 3 independent experiments. (B) qRT-PCR
quantification of Rag1, Rag2, and p21 mRNA in non-irradiated or irradiated EμBCL2 preB cells at indicated times after exposure to 4 Gy of IR. Cells were treated with 10 μM of
the ML120B IKKβ kinase inhibitor or vehicle (DMSO) for 2 hours prior to irradiation. Data
are from 3 independent experiments. (C) qRT-PCR quantification of Rag1, Rag2, and p21
mRNA in BM from NF-κB1-/- mice. BM was harvested and pre-incubated for 2 hours at
37°. After pre-incubated, BM from each mouse was divided into two samples and either
unirradiated or exposed to 4 Gy IR; RNA was collected 4 hours later. Data are from one
experiment with 4 mice.
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Figure 3.6

Figure 3.6: LPS treatment suppresses Rag1 and Rag2 mRNA in a manner similar to DSBs.
qRT-PCR quantification of Rag1 and Rag2 mRNA in EμBCL2 pre-B cells treated with 15
μg/mL LPS or vehicle (water) for the indicated time periods. Data are from 3
independent experiments.
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Supplemental Figure 3.1

Sup. Fig. 3.1: Constitutive Gadd45α expression does not prevent suppression of Rag1
and Rag2 mRNA expression by DSBs. (A) qRT-PCR quantification of Gadd45α mRNA in
non-irradiated or irradiated EμBCL2 pre-B cells at indicated times after exposure to 4 Gy
IR. Data are from 11 independent experiments. Data are normalized to 1.0 for nonirradiated cells. For irradiated cells, data averages are shown with error bars indicating
SEM. p-values calculated using Dunnett's post-test after ANOVA. ***p<0.001. (B) qRTPCR quantification of EU-labeled Gadd45α mRNA levels relative to EU-labeled Hprt
mRNA levels in non-irradiated EμBCL2pre-B cells and irradiated EμBCL2 pre-B cells at
indicated times after addition of EU and exposure to 4Gy of IR. Data are presented as
the ratio of relative levels of each mRNA in irradiated cells compared to non-irradiated
cells. The dotted line represents a value of 1, which would indicate that IR had no effect
on the transcription rate of an assayed gene. Data are from 4 independent experiments.
p-values were determined using one-tailed T test with Bonferroni's correction for
multiple testing. ***p<0.001.(C) qRT-PCR quantification of Rag1 and Rag2 mRNA in nonirradiated and irradiated Rag1D708A Abl pre-B cells transduced with an empty retroviral
vector or the same retroviral vector containing an ERGadd45α cDNA. For 2 hours before
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harvesting non-irradiated cells or exposing to IR the irradiated cells, all cells were
treated with tamoxifen to induce nuclear translocation of ER-Gadd45α. Data are from
one representative experiment. (D) Western blot showing ER-Gadd45α and actin
expression in Rag1D708A Abl pre-B cells transduced with an empty retroviral vector or the
same retroviral vector containing an ER-Gadd45α cDNA. Data are from one experiment.
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Supplemental Figure 3.2

Sup. Fig. 3.2: p53 activity is not required for suppression of Rag1 and Rag2 mRNA
expression by DSBs. qRT-PCR quantification of Rag1 and Rag2 mRNA in non-irradiated
VavCre+Tp53flox/flox pre-B cells or irradiated VavCre+Tp53flox/flox pre-B cells at indicated
times after exposure to 4 Gy IR. Data are from 2 independent experiments. Data are
normalized to 1.0 for non-irradiated cells harvested one hour following IR exposure of
irradiated samples. For other samples, data averages are shown with error bars
indicating SEM.
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Supplemental Figure 3.3

Sup. Fig. 3.3: Phosphorylated IKKα/IKKβ accumulates rapidly and transiently in IL-7
withdrawn pre-B cells in response to DSBs. Western blot showing phosphorylated and
total IKKα/IKKβ in unirradiated pre-B cells or pre-B cells exposed to 4 Gy IR. The
antibodies used cannot distinguish between IKKα and IKKβ.
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Supplemental Figure 3.4

Sup. Fig. 3.4: Expression of factors involved in NF-κB signaling changes throughout B cell
development. The heatmap was generated using "my dataset" tool in the Immgen
database (www.immgen.org). All BM B cell subsets and an early splenic subset (T1) were
used to generate the heatmap. The list of factors involved in NF-kB signaling was based
on a comprehensive review of NF-kB published in 2012 (Hayden and Ghosh, 2012).
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Chapter 4: Impact of DSB signaling on allelic exclusion 1
Abstract
Chapters 2 and 3 described the ability of exogenously induced DSBs to activate
ATM and Nemo to suppress Rag1 and Rag2 expression in pro-B cells, pre-B cells, and DN
thymocytes. A similar suppressive signal activated by RAG cleavage in pre-B cells had
previously been correlated with increased Igκ allelic inclusion. Here, we show that ATM
also regulates allelic exclusion of the IgH chain rearranged in pro-B cells and the TCRβ
chain rearranged in DN thymocytes. Increased TCRβ allelic inclusion is established early
in T cell development and is correlated with an increased frequency of T cells containing
two TCRβ rearrangements, indicating a failure of allelic exclusion at level of TCRβ
rearrangement. We also investigated the role of several factors proposed to cooperate
with or act downstream of ATM in promoting allelic exclusion. We found that the cell
cycle regulator cyclin D3 has only a minor role in Igκ allelic inclusion despite its more
prominent role in IgH and TCRβ allelic inclusion. Spi-C, which has been proposed to
suppress Igκ locus accessibility in the presence of DSBs, was found to be unnecessary for
allelic exclusion. In contrast, we find that Nemo-deficient B cells have increased Igκ

1

Parts of this chapter were published in The Journal of Immunology. Copyright © 2014 The American
Association of Immunologists, Inc. Steinel NC, Fisher MR, Yang-Iott KS, Bassing CH. The Ataxia
Telangiecetasia Mutated and Cyclin D3 Proteins Cooperate to Help Enforce TCRβ and IgH Allelic Exclusion.
J. Immunol. 193:2881-2890. Portions of this chapter were prepared jointly with Natalie Steinel.
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allelic inclusion, further supporting a role for Nemo-mediated suppression of Rag1 and
Rag2 expression in promoting allelic exclusion.

Introduction
Even before the discovery of V(D)J recombination, it was recognized that each B
cell expresses only one IgH and one IgL chain on their cell surface, despite the
availability of multiple alleles; this phenomenon is known as allelic exclusion (Bernier
and Cebra, 1964; Pernis et al., 1965). At a genetic level, it was found that B cells typically
contain only one productively rearranged IgH gene and one functional IgL gene, while T
cells have only one productively rearranged TCRβ gene (Alt et al., 1980, 1984; Casanova
et al., 1991). However, the TCRα chain does not appear to be allelically excluded at
either the level of genetic rearrangement or cell surface expression (Casanova et al.,
1991; Heath et al., 1995).
If allelic exclusion did not occur at the genetic level, it would be predicted that
V(D)J 100% of cells would contain two rearrangements for each antigen receptor chain,
and that many cells would contain two productive rearrangements. For IgH and TCRβ
loci the upper limit of cells that could contain two productive rearrangements is 20%, as
2/3 of all rearrangements are out-of-frame, and each IgH or TCRβ allele can undergo
rearrangement only once. On the other hand, if allelic exclusion operated perfectly at
the genetic level, it would be predicted that approximately 60% of B and T cells would
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have only one fully rearranged IgH or TCRβ gene (Alt et al., 1984; Malissen et al., 1992).
By definition, 0% of those lymphocytes would contain two productive rearrangements
for the same antigen receptor gene in this case. In fact, IgH, Igκ, and TCRβ
rearrangements show strong evidence for allelic inclusion at the genetic level, in that
close to 60% of B and T cells contain only 1 rearranged IgH or TCRβ allele, and very few
lymphocytes contain two productive rearrangements for the same antigen receptor
chain (Alt et al., 1984; Casanova et al., 1991). However, allelic inclusion at the genetic
level is generally somewhat higher than inclusion at the level of cell surface antigen
receptor expression. Factors accounting for this gap include the requirement for pairing
of IgH and IgL or TCRβ and TCRα chains and post-transcriptional silencing of one allele
(Brady et al., 2010)
Several mechanisms cooperate to enforce allelic exclusion of antigen receptor
gene rearrangements. Most famous is feedback inhibition by the protein products of
functionally rearranged antigen receptor genes. These proteins assemble into cell
surface complexes that generate signals to inhibit subsequent gene rearrangement. In
pro-B cells that create a productive IgH rearrangement, the new IgH chain pairs with
surrogate light chains (VpreB and λ5) and the signaling components of the BCR (Igα and
Igβ) to form the pre-BCR; inability of this heavy chain to signal prevents feedback
inhibition and allows cells to create multiple productive IgH rearrangements (Kitamura
and Rajewsky, 1992; Papavasiliou et al., 1995; Schweighoffer et al., 2003). Similarly,
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creation of a functional light chain in pre-B cells allows cell surface expression of the
complete BCR, which signals feedback inhibition of further Igκ or Igλ rearrangement
(Grawunder et al., 1995). A similar situation is found in DN thymocytes; a newly
synthesized TCRβ chain pairs with the pre-Tα chain to form the pre-TCR, and inability of
the pre-TCR to signal leads to the generation of cells with two productive TCRβ alleles
(Aifantis et al., 1997, 1999). The feedback signal acts both by turning off RAG expression
(Grawunder et al., 1995; Hoffman et al., 1996; Li et al., 1993), and by alterations in
chromatin structure and 3D DNA organization of the excluded locus to preclude RAG
activity (Corcoran, 2005; Roldán et al., 2005; Kondilis-Mangum et al., 2011).
It is important to note that feedback inhibition can only prevent allelic inclusion
if rearrangements do not occur simultaneously. Indeed, several studies using FISH and γH2AX staining to mark antigen receptor loci with DSBs show that normally, only one
cleaved allele exists in a cell (Hewitt et al., 2009; Chaumeil et al., 2013; Chan et al.,
2013). The Bergman laboratory has provided evidence that one of the two homologous
alleles for IgH, Igκ, and TCRβ is marked to rearrange earlier than the other by epigenetic
marks established early in development, so one allele is predisposed to initiate
recombination before the other (Mostoslavsky et al., 1998, 2001; Goldmit et al., 2005).
Additionally, it is possible that initiation of rearrangement is a relatively rare event, so
that the likelihood of two rearrangements occurring simultaneously in the same cell is
very low.
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The Bassing laboratory showed that in pre-B cells, a third allelic exclusion
mechanism acts in the time between initial cleavage of one Igκ allele and initiation of
feedback inhibition by cell surface expression of a complete BCR. Cleavage of Igκ
activates the DNA damage response protein ATM, which inhibits cleavage of the second
allele before the first is repaired (Steinel et al., 2013). Importantly, inhibition of V(D)J
recombination must be transient, as a second recombination event will occur if the first
is non-productive.
ATM deficient mice lacking this transient inhibition of V(D)J recombination have
an increased frequency of B cells expressing two different Igκ chains on the cell surface,
a failure of allelic exclusion (Steinel et al., 2013). More recently, we have found that
ATM deficient mice also have increased allelic inclusion of IgH and TCRβ chains which
rearrange in pro-B cells and DN thymocytes, respectively. We have further explored the
genetic and developmental basis of increased TCRβ allelic inclusion in ATM-deficient T
cells. We find that increased ATM-deficient T cells have a relatively high proportion of
cells with two rearranged TCRβ alleles, consistent with our hypothesis that the defect in
allelic exclusion is at the level of rearrangement. Furthermore, we find that this defect is
already present in pre-selection DP thymocytes. Finally, we examined the effect of
several molecules proposed to either participate in or cooperate with the ATMmediated inhibition signal on Igκ allelic exclusion. We find that the cell cycle regulatory
protein cyclin D3 has a modest role in promoting Igκ allelic exclusion. The Igκ locus
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regulatory protein Spi-C was not required for allelic exclusion of the Igκ locus. In
contrast, Nemo-deficient B cells show a defect in allelic exclusion of approximately the
same magnitude as ATM-deficient cells.

Results
Increased frequency of lymphocytes expressing two IgH or TCRβ chains in ATM-/- mice
The importance of ATM-mediated inhibition of V(D)J recombination for Igκ allelic
exclusion led us to question whether a similar mechanism operates in pro-B and pro-T
cells, which rearrange IgH and TCRβ genes, respectively. To measure IgH allelic inclusion
we took advantage of naturally occurring IgM allotypes, IgMA vs. IgMB. We performed
cell surface staining for these two markers using ATM+/+ IgμA/B and ATM-/- IgμA/B BM cells.
We found that approximately 0.4% of ATM-/- IgμA/B BM cells expressed both IgMA and
IgMb, compared to approximately 0.25% of ATM+/+ IgμA/B cells (Fig. 4.1a&b). Although
these frequencies are low, it is important to note both asynchronous initiation of
rearrangement and feedback inhibition from a complete antigen receptor are not
expected to be affected by ATM deficiency, and would both still limit the frequency of
allelically included cells. We performed similar flow cytometry experiments to measure
allelic inclusion of the TCRβ chain. Lacking allotypic markers for TCRβ, we conducted this
analysis using pairs of antibodies that recognize different Vβ segments. Because ATM-/thymocytes exhibit defects in both D-to-J rearrangement and V-to-DJ rearrangement
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which might limit the frequency of productive biallelic rearrangement, we used Jb1DJ/DJ
mice in these analyses to limit the opportunity for aberrant recombination events that
would decrease observed allelic inclusion. In these mice, the TCRβ loci contain a Dβ1-toJβ1 rearrangement encoded in the germline and deletion of Dβ2 and Jβ2, and so only
undergo V-to-DJ rearrangement of TCRβ (Carpenter et al., 2009). For most Vβ pairs
tested, we found that ATM-/- Jb1DJ/DJ thymocytes showed a trend towards increased
double expression, and this difference was significant for several pairs (Fig. 4.1c&d).
These results support a role for ATM in enforcing allelic exclusion of both IgH and TCRβ.
Increased allelic inclusion of TCRβ is evident in DP thymocytes
As described in Chapter 3, ATM inhibits RAG expression in response to DNA
damage. This suggests that ATM regulates allelic exclusion at the level of antigen
receptor gene rearrangement. However, it is also possible that ATM affects selection
processes that might affect the ability of cells expressing two different IgH or TCRβ
chains to survive and progress through development (Balomenos et al., 1995). To
address this issue we measured TCRβ inclusion in earlier stages of T cell development in
thymocytes from either developing ATM+/+ Jb1DJ/DJ and ATM-/- Jb1DJ/DJ mice. We
performed surface staining for CD4 and CD8 to divide cells into DN, DP, and SP
developmental stages. We then performed intracellular staining for pairs of Vβ chains,
to allow detection of TCRβ chains not yet expressed on the cell surface. As expected,
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relatively few cells in the DN population expressed Vβ chains. Unfortunately, this fact
combined with the low frequency of DN thymocytes prevented us from reliably
detecting dual Vβ expressing cells among either ATM+/+ Jb1DJ/DJ or ATM-/- Jb1DJ/DJ cells
(Fig. 4.2a). In contrast, dual Vβ expressing cells were easily detected among DP
thymocytes (Fig. 4.2a). For each Vβ pair tested, ATM-/- Jb1DJ/DJ DP thymocytes had an
increased frequency of dual expressing cells (Fig. 4.2b). Although we cannot completely
rule out a role for selection, this result shows that increased allelic exclusion of TCRβ in
ATM-/- cells is established early in thymocyte development.
ATM-deficient T cells exhibit increased biallelic rearrangement of TCRβ genes
In the case of Igκ allelic exclusion, ATM was shown to promote allelic exclusion
by inhibiting RAG-mediated cleavage of a second allele before repair of the first cleaved
Igκ allele. If a similar mechanism operates in pro-B cells rearranging IgH genes and in DN
thymocytes rearranging TCRβ genes, we would predict that an increased frequency of
mature lymphocytes would have two completely rearranged IgH or TCRβ genes. We
used two methods to test this prediction. We used a fluorescence in situ hybridization
(FISH) assay to measure the frequency of ATM+/+ Jb1DJ/DJ and ATM-/- Jb1DJ/DJ T cells with
one vs. two V-to-DJ rearrangements of the TCRβ locus. In this assay, we labeled cells
with two probes; one that hybridizes to the region downstream of the J segments,
which is present on all intact TCRβ alleles. The second hybridizes between the V
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segments and the pre-rearranged DJ segment. This probe only hybridizes if the allele has
not undergone rearrangement. Thus, a VDJ rearrangement is identified by labeling with
only the downstream probe, while an unrearranged allele is labeled with both probes
(Fig. 4.3a). Certain aberrant rearrangement events can also be identified in this system;
for example hybridization of the two probes to different chromosomes indicates a
translocation event, while hybridization of probe(s) to only one chromosome in a cell
indicates a large deletion event on one allele. Examples of these scenarios are shown in
Fig. 4.3b. Notably, small deletion events that might nevertheless affect the productivity
of a rearrangement are not detected by this method. In the case of perfect allelic
exclusion, we would predict that 60% of T cells would contain one complete VDJ
rearrangement. Using this technique, we found that approximately 65% of ATM+/+
Jb1DJ/DJ T cells contained only one complete VDJ rearrangement, similar to the 60%
predicted in the case of perfect allelic exclusion. In contrast, only 53% of ATM-/- Jb1DJ/DJ T
cells contained one complete V(D)J rearrangement, a significant decrease compared to
the wild type cells (Fig. 4.3c). We also found an increased frequency of aberrant
rearrangement events in ATM-/- Jb1DJ/DJ T cells (Fig. 4.3d).
The FISH analysis cannot address the question of whether any of the cells with
two complete rearrangements contain two productive rearrangements. To address this
question, we generated a panel of T cell hybridomas from ATM-/- Jb1DJ/DJ spleen cells and
analyzed the rearrangement status of their TCRβ loci by Southern as previously
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described (Khor and Sleckman, 2005). We obtained a total of 171 clones in this analysis;
38 were rejected from the analysis because only a single TCRβ band could be detected
by southern. This might be caused by loss of an allele during hybridoma fusion or
aberrant rearrangement, both of which might be affected by ATM deficiency. Of the
remaining 133 clones, 87 (65.4%) contained only one complete VDJ rearrangement (Fig.
4.3e). We further analyzed the 46 hybridoma lines containing two complete
rearrangements to determine if any of these contained two productive rearrangements.
We first identified the Vβ segments involved in rearrangement by a PCR screen, and
then sequenced the PCR products obtained. Four lines were excluded at this step
because we were unable to obtain two sequences. Of the remaining 42 clones, 3 (7.1%)
contained two productive rearrangements (Fig. 4.3f). A older study examining wild-type
hybridomas detected no examples of T cell hybridomas with two productive
rearrangement (Khor and Sleckman, 2005). The frequency of ATM-/- Jb1DJ/DJ containing
two VDJ rearrangements (65.4%) is similar to the amount predicted in the case of
perfect allelic exclusion, but the presence of 3 lines containing two productive
rearrangements indicates a defect in allelic exclusion.
Cyclin D3 deficiency leads to a minor defect in allelic exclusion of Igκ
Having established the importance of ATM for allelic exclusion of IgH, TCRβ, and
Igκ loci, we wanted to identify other factors that either participate in the ATM-mediated
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regulation of allelic exclusion or complement ATM's activity. Work by Natalie Steinel in
the Bassing lab showed that the cell cycle regulatory protein cyclin D3 helps enforce
allelic exclusion of the IgH and TCRβ loci, and that double deficiency of ATM and cyclin
D3 have an additive effect on allelic inclusion (Steinel et al., 2014). Normally, cyclin D3
promotes the proliferative expansion that occurs upon expression of a pre-BCR or preTCR, as developing lymphocytes transition from the pro- to pre-B or T cell stage (Sicinska
et al., 2003; Cooper et al., 2006). As this proliferation is believed to play a part in both
RAG downregulation and chromatin alterations of IgH and TCRβ loci, it was suggested
that cyclin D3 deficiency increases allelic inclusion in ATM+/+ or ATM-/- lymphocytes by
increasing the time available for a second recombination event after the first is
completed. However, cyclin D3 was also shown to repress germline VH transcription in
pro-B cells, indicating that it may also promote allelic exclusion by directly suppressing
accessibility of antigen receptor loci to the RAG recombinase (Powers et al., 2012). As
pre-B cells do not undergo a proliferative burst following expression of the BCR, cyclin
D3's role in promoting proliferation would not be expected to affect Igκ allelic exclusion
in pre-B cells. However, if cyclin D3 has a role in directly regulating Igκ accessibility, it
might impact Igκ allelic exclusion in this way. To test the role of cyclin D3 in Igκ allelic
exclusion, we used the mice in which one Igκ constant region allele was replaced with
the equivalent human gene (Igκh), while the other allele was wild type (Igκm) allowing
the two Igκ alleles to be stained by two different antibodies (Casellas, 2001). We found
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that the frequency of cells expressing Igκm and Igκh together was slightly higher in
Ccnd3-/- Igκh/m BM cells than in Ccnd3+/+ Igκh/m BM cells, approximately 2.25 % compared
to 1.9% (Fig. 4.4a&b). Among splenic B cells, no significant increase in Igκ biallelic
expression was found in Ccnd3-/- Igκh/m cells (Fig. 4.4 a&b). This very small increase in Igκ
allelic inclusion, which does not persist in the periphery, is far less than the
approximately 2-fold increase in IgH allelic inclusion found in Ccnd3-/- B cells. Therefore,
cyclin D3 appears to play at most a minor role in promoting Igκ allelic exclusion.
Spic deficiency does not affect allelic exclusion of Igκ
It has been proposed that DSBs regulate accessibility of the Igκ locus in addition
to suppressing Rag1 and Rag2 expression. In this context, RAG mediated DSBs have
been shown to act through ATM to increase expression of the Ets family protein Spi-C
(Bednarski et al., 2016). Spi-C lacks the ability to activate transcription, and has been
shown to inhibit the activity of transcriptionally activate Ets family members by
competing for binding (Hashimoto et al., 1999; Schweitzer et al., 2006). In the context of
RAG-mediated DSBs, Spi-C overexpression was shown to partially inhibit Igκ cleavage in
ATM-/- pre-B cells that would otherwise experience no inhibition of Igκ cleavage
(Bednarski et al., 2016). In light of these findings, we hypothesized that increased Spi-C
expression may decrease accessibility of the Igκ locus and cooperate with the
suppression of Rag1 and Rag2 expression to promote allelic exclusion. Indeed, in the Igκ
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cleavage assays discussed in Chapter 2 (Fig. 2.5a), the accumulation of cleaved Igκ alleles
that occurs upon treatment of Artemis-/- cells with sti571 is accompanied by increased
Spic mRNA expression; addition of the DNA damaging agent etoposide might cause a
slight additional increase (Fig. 4.5a). To determine whether Spi-C expression is necessary
to enforce allelic exclusion of the Igκ locus, we performed flow cytometry on Spic+/+
Igκh/m and Spic-/- Igκh/m BM cells and splenocytes. We observed approximately normal
frequencies of pre-B cells in Spic-/- Igκh/m BM cells, although they express to have slightly
increased levels of CD43 expression, and slightly decreased levels of B220 (Fig. 4.5b);
this might be due to defects in regulating pre-B cell-specific gene expression.
Nevertheless, we found no defect in Igκ allelic exclusion in the BM, and actually found a
slight decrease (approximately 20%) in allelic inclusion among Spic-/- Igκh/m splenocytes
(Fig. 4.5c). These results show that Spi-C expression is not necessary for normal Igκ
allelic exclusion.
Nemo deficiency causes an increase in Igκ allelic inclusion
In Chapter 3 we described a role for Nemo in mediating suppression of Rag1 and
Rag2 expression. As Nemo is a known target of ATM activity, we propose that Nemo
acts downstream of ATM to mediated suppression. As discussed above, developing
lymphocytes that lack this pathway due to ATM-deficiency exhibit increased allelic
inclusion of IgH, TCRβ, and Igκ (Fig. 4.1 and Steinel et al., 2013). To determine if Nemo104

deficiency has a similar effect on allelic inclusion of Igκ, we performed flow cytometry
on Nemo+/+ Igκh/m and Nemo-/- Igκh/m BM cells and splenocytes. In accordance with the
known survival defect of mature Nemo-/- B cells, we found relatively few of the most
mature B220high cells in Nemo-/- Igκh/m BM (Fig. 4.6a and Sasaki et al., 2006). As we have
previously observed that these mature cells tend to exhibit the highest levels of allelic
inclusion, we analyzed Igκh and Igκm expression both in total B220+ CD43- cells (Fig. 4.6a,
red box), and in the less mature B220intermediate CD43- population (Fig. 4.6b, blue box). In
both cases we found an approximately 50% increase of Igκh/Igκm dual expressing cells
among Nemo-/- Igκh/m BM cells compared to Nemo+/+ Igκh/m (Fig. 4.6b). We found a
similar 50% increase in allelic inclusion in Nemo-/- Igκh/m splenocytes. In contrast, Atm-/Igκh/m BM cells and splenocytes exhibit an approximately 2-fold increase in Igκ allelic
inclusion (Steinel et al., 2013). These results are consistent with the mechanistic data
presented in Chapter 3, where we show that ATM is absolutely required for suppression
of Rag1 and Rag2 expression in response to DSBs, while Nemo is only partially
responsible for this suppression. Together, these data are consistent with a role for
Nemo in enforcing allelic exclusion, likely as one downstream effecter of ATM activity.

Discussion
Steinel et al. originally proposed that ATM regulates allelic exclusion through its
role in inhibiting Rag1 and Rag2 expression in response to a RAG-mediated DSB (Steinel
et al., 2013). Here, we demonstrate several parallels between the regulation of allelic
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exclusion and the regulation of Rag1 and Rag2 expression by DSBs. First, we find that
DSBs suppress Rag1 and Rag2 expression in pro-B and pre-B cells and in DN thymocytes,
the cell subsets that rearrange the allelically excluded antigen receptor chains IgH, Igκ,
and TCRβ. Conversely, pre-T cells rearranging the non-allelically excluded TCRα chain do
not suppress Rag1 and Rag2 expression in response to DSBs. This finding suggests
suppression of Rag1 and Rag2 expression by DSBs is common mechanism for enforcing
allelic exclusion, similar to the common role of inhibition from cell surface antigen
receptors and asynchronous initiation of recombination (Mostoslavsky et al., 2004).
Furthermore, we find that ATM is important for promoting allelic exclusion of IgH and
TCRβ, consistent with a role for DSB-mediated suppression of Rag1 and Rag2 expression
in promoting allelic expression in pro-B cells and DN thymocytes. Finally, we find that
the NF-κB regulatory protein Nemo plays a role in both regulation of Rag1 and Rag2
expression by DSBs and in allelic exclusion. Collectively, these results provide strong
support for the hypothesis that feedback inhibition by RAG-mediated DSBs plays an
important role in promoting allelic exclusion.
Notably, the inability of constitutive Rag1 expression to restore V(D)J
recombination activity in pre-B cells experiencing etoposide-induced DSBs (Fig. 2.6e)
suggests that the inhibitory signal may involve more than simply suppression of Rag1
and Rag2 transcription. Additional factors might involve post-translational modification
of Rag1 and/or Rag2 proteins or decreased accessibility of antigen receptor loci.
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Additional experiments will be necessary to determine the relative importance of Rag1
and Rag2 mRNA suppression and alternative mechanisms in promoting allelic exclusion.
We did not find a role for Spi-C in enforcing Igκ allelic exclusion, despite the
published finding that Spi-C expression is induced by RAG-mediated cleavage of Igκ and
can suppress Igκ cleavage in the absence of ATM activity (Bednarski et al., 2016). The
published data shows Spi-C induction and activity over the course of days; it is possible
that Spi-C induction is irrelevant in the much shorter timeframe of normal V(D)J
recombination cleavage and repair. Indeed, we see induction of Spic mRNA expression
when measuring Igκ cleavage in a pre-B cell line over the course of three days; however
we do not see any induction within four hours of exposing primary pre-B cells to IR or
etoposide (Fig. 4.5a and data not shown). Furthermore, the effect of Spi-C on Igκ
cleavage was only shown in ATM-deficient cells; it is possible that it is relatively
unimportant in the presence of normal ATM activity. In this respect, it is possible Spi-C
induction complements the function of other factors acting downstream of ATM, such
as suppression of Rag1 and Rag2 expression. Additional experiments will be necessary
explore the possibility that Spi-C induction and suppression of Rag1 and Rag2
expression act synergistically to inhibit V(D)J recombination and promote allelic
exclusion.
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Figure 4.1

Figure 4.1: Increased allelic inclusion of IgH and TCRβ in ATM-deficient mice. (A)
Representative flow cytometry analysis showing cell surface expression of allotypically
marked IgM proteins in Atm+/+Jb1DJ/DJ or AtmJb1DJ/DJ mice B220+ BM cells. (B)
Representative flow cytometry analysis showing cell surface expression of Vβ8 and Vβ14
among Atm+/+Jb1DJ/DJ or AtmJb1DJ/DJ mice TCRβ+ thymocytes. (C) Quantification of
dual IgM expressing B cells as shown in (A). (D) Quantification of thymocytes with dual
expression of the indicated Vβ pairs as shown in (B). p values determined by t-test. Error
bars indicate SEM.
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Figure 4.2

Figure 4.2: Increased allelic inclusion in ATM-deficient thymocytes is established by the
DP stage of development. (A) Representative flow cytometry analysis of intracellular
expression of Vβ14 and Vβ8 expression in DN or DP thymocytes isolated from
Atm+/+Jb1DJ/DJ or Atm−/−Jb1DJ/DJ mice. The circle gates indicate where cells expressing
equivalent high levels of both Vβ14 and Vβ8 should be visualized. DN thymocytes lacked
detectable populations of Vβ14+Vβ8+ cells, whereas DP thymocytes contained
populations that comprised the indicated percentage of DP cells. (B) Quantification of
the average frequencies of DP thymocytes that express each indicated combination of
Vβ chains in their cytoplasm as depicted in (A). Data are from two independent
experiments conducted on a total of seven Atm+/+Jb1DJ/DJ and eight Atm−/−Jb1DJ/DJ
littermate mice. Error bars indicate SEM.
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Figure 4.3

Figure 4.3: ATM-deficient T cells include a high frequency of cells with two TCRβ VDJ
rearrangements. (A) Schematic of the TCRβ locus including with pre-rearranged Jb1DJ/DJ
allele. Red and green lines indicate areas of probe hybridization for FISH analysis. (B)
Examples of cells containing 2 rearranged TCRβ alleles (VDJ/VDJ), 1 rearranged allele
and 1 unrearranged allele (VDJ/DJ), or 1 rearranged allele and a deletion of the second
allele (VDJ/Ø). (C) Frequency of Atm+/+Jb1DJ/DJ or Atm-/-Jb1DJ/DJ spleen cells with one vs.
two rearranged TCRβ alleles, as measured by FISH. p value calculated by chi-square test.
(D) Frequency of aberrant rearrangement events (deletions, translocations,
duplications) in Atm+/+Jb1DJ/DJ vs. Atm-/-Jb1DJ/DJ spleen cells containing at least one TCRβ
rearrangement, as measured by FISH. p value calculated by chi-square test. (E)
Frequency of cells with one vs. two TCRβ rearrangements as determined by Southern
analysis of ATM-/- Jb1DJ/DJ T cell hybridoma lines. (F) Frequency of cells with one vs. two
productive TCRβ rearrangements as determined by PCR and Sanger sequencing of TCRβ
rearrangements from ATM-/- Jb1DJ/DJ T cell hybridoma lines.
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Figure 4.4

Figure 4.4: Ccnd3-/- B cells exhibit a modest increase in Igκ allelic inclusion. (A)
Representative FACS plots showing Igκh and Igκm expression in Ccnd3+/+ Igκh/m and
Ccnd3-/- Igκh/m BM and spleen cells. The gate represents cells expressing equivalently
high levels of both Igκh and Igκm. (B) Quantification of B220+ CD43- Ccnd3+/+ Igκh/m and
Ccnd3-/- Igκh/m BM and spleen cells expressing both Igκh and Igκm as depicted in (A). pvalues determined by t-test. Error bars represent SEM.
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Figure 4.5

Figure 4.5: Spic-/- B cells exhibit normal Igκ allelic inclusion. (A) Spic mRNA expression in
Artemis-/- Abelson pre-B cells exposed to sti571 alone or sti571 and etoposide for the
indicated times. (B) Representative FACS plots showing Igκh and Igκm expression in
Spic+/+ Igκh/m and Spic-/- Igκh/m BM and spleen cells. The gate represents cells expressing
equivalently high levels of both Igκh and Igκm. (C) Quantification of B220+ CD43- Spic+/+
Igκh/m and Spic-/- Igκh/m BM and spleen cells expressing both Igκh and Igκm as depicted in
(B). p-values determined by t-test. Error bars represent SEM.
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Figure 4.6

Figure 4.6: Nemo/- B cells exhibit increased in Igκ allelic inclusion. (A) Representative
FACS plots showing Igκh and Igκm expression in Nemo+/+ Igκh/m and Nemo-/- Igκh/m BM and
spleen cells. The gate represents cells expressing equivalently high levels of both Igκh
and Igκm. (B) Quantification of B220+ CD43- cells or B220intermediate CD3- Nemo+/+ Igκh/m
and Nemo-/- Igκh/m BM and spleen cells expressing both Igκh and Igκm as depicted in (A).
p-values calculated by t-test. Error bars represent SEM.
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Chapter 5: Discussion
V(D)J recombination is crucial for lymphocyte development and immune
function, but poses risks at multiple levels. Deliberate cleavage and rearrangement of
DNA could lead to genomic instability and malignant transformation (Schlissel, 2006).
The largely random nature of the final product necessitates stringent selection
processes to promote the development of cells with useful receptors and eliminate
those with potentially harmful ones (Pelanda and Torres, 2012; Xing and Hogquist,
2012). In light of these hazards, it has long been recognized that lymphocytes carefully
regulate V(D)J recombination in many respects. Most obviously, V(D)J recombination is
strictly limited to developing lymphocytes, and specific rearrangement events are
restricted to certain developmental windows. Within those windows, it is generally
found that only one antigen receptor gene rearranges at a time (Hewitt et al., 2009;
Chan et al., 2013; Chaumeil et al., 2013). This asynchronous recombination, combined
with feedback signals generated by newly synthesized antigen receptors, leads to allelic
exclusion of several antigen receptors (Brady et al., 2010). In this work, we describe a
signal originating from DNA double strand breaks, which activates a conserved DNA
damage response pathway involving ATM and Nemo. We build on previous work from
the Bassing laboratory to show that this pathway helps to promote allelic exclusion in
developing B and T cells.
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Regulation of Rag1 and Rag2 expression
The regulation of Rag1 and Rag2 expression has mostly been studied in
relationship to developmental signals. Most notably, many factors that turn on Rag1
and Rag2 expression at appropriate stages of T and particularly B cell development have
been identified. The previously identified suppressive signals originate from cell-surface
antigen receptors, which have long been known to turn off Rag1 and Rag2 expression
(Li et al., 1993; Turka et al., 1991). The work presented in this dissertation shows that a
very different kind of stimulus, DNA damage, can also turn off Rag1 and Rag2
expression. We also find that LPS stimulation suppresses Rag1 and Rag2 expression in
pre-B cells. These findings suggest that Rag1 and Rag2 expression is subject to more
complex regulation than has generally been considered. Additional work will be
necessary to determine how these signals affect lymphocyte development in vivo.
A model of our findings and open questions regarding the mechanism by which
RAG-mediated or exogenous DSBs suppress V(D)J recombination is depicted in Fig. 5.1.
To summarize, we have shown that DSBs activate ATM, which is required for
transcriptional suppression of Rag1 and Rag2. Loss of Rag1 and Rag2 transcripts is
accompanied by loss of Rag1 protein. Lack of the complete RAG recombinase prevents
cleavage of antigen receptor loci. However, the inability of Rag1 reconstitution alone to
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promote Igκ cleavage in the presence of DSBs (Fig. 2.6) suggests that additional signals
may act in parallel to suppress V(D)J recombination in the presence of DSBs.
The role of NF-κB factors in regulating Rag1 and Rag2 expression will be of
particular interest. As discussed in Chapter 3, the literature on this subject and our own
work present several apparent contradictions. Ambiguity in precisely which NF-κB
factors are manipulated in different studies may account for some of this confusion. Our
own work shows that two different IKKβ inhibitors have different effects on Rag1 and
Rag2 expression. The more specific inhibitor leads to a slight increase in Rag1 and Rag2
expression in pre-B cells and partially prevents suppression upon IR exposure. Another
inhibitor that affects IKKα as well as IKKβ leads to a slight decrease in Rag1 expression
and a substantial decrease in Rag2 expression, which makes the effect of IR difficult to
interpret. These results suggest that both IKKs have a modest basal effect on Rag1 and
Rag2 expression, and that these effects oppose each other.
Another possibility is that the effect of NF-κB signaling may change during the
course of development. Expression of many NF-κB factors changes as cells approach
maturity (Sup. Fig. 3.4 and Kistler et al., 1998); a change in the relative expression in
different factors might change the target genes they bind to and their activating or
inhibitory effects on transcription of those genes. One study to date that shows an
inhibitory effect of NF-κB signaling on Rag1 and Rag2 expression dealt with expression
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in immature B cells (Verkoczy et al., 2005). It is possible that NF-kB signaling earlier in
development could have different effects. It is also possible that different stimuli that
activate NF-κB might simultaneously activate other signaling pathways that interact with
and modify NF-κB signals.
Potential role for parallel signals in suppressing V(D)J recombination
The failure of constitutive Rag1 mRNA expression to restore V(D)J recombination
activity in the presence of etoposide suggests that additional signals beyond
suppression of Rag1 expression are involved. Given the demonstrated involvement of
ATM, direct phosphorylation of Rag1 or Rag2 proteins may occur. Inactivation by
phosphorylation could have the advantage of acting more rapidly than transcriptional
suppression of Rag1 and Rag2, as it takes some time to deplete the Rag1 protein pool
by degradation. Both proteins contain motifs that could be targeted by ATM or DN-PKcs,
a related kinase that is also activated by RAG-mediated DSBs (Gapud et al., 2011).
Phosphorylation by other kinases might also play a role. One study
demonstrated that some Rag2 protein is exported from the nucleus following IR, and
that export requires the cdk-phosphorylation site T490 (Rodgers et al., 2015). Regulated
degradation of Rag2 at the G1/S checkpoint also depends on phosphorylation of T490
(Jiang et al., 2005). However given that neither we nor the Rodgers group observe
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degradation of Rag2 protein upon IR, T490 phosphorylation may play another role in
this circumstance.
Another potential method of suppressing RAG activity is to decrease the
accessibility of target antigen receptor loci. In this regard, we looked for a role for the
Ets-family member Spi-C, which was recently shown to decrease Igκ locus accessibility,
presumably by competing with transcriptionally active Ets family (Bednarski et al.,
2016). Although we confirmed the finding that Spi-C is induced in cells accumulating
RAG-mediated DSBs, we did not find a role for this protein in allelic exclusion. It is
possible that it plays a secondary role, perhaps complementing the effect of suppression
of Rag1 and Rag2 expression. As-yet unidentified factors acting at antigen receptor loci
may also play a role.
Allelic exclusion and genomic stability
The results presented in Chapter 4 and previously published studies suggest that
ATM suppresses allelic inclusion by promoting monoallelic rearrangement of antigen
receptor alleles (Chaumeil et al., 2013; Steinel et al., 2013). Monoallelic rearrangement
may also be important for genomic stability of developing lymphocytes, as formation of
a productive rearrangement that leads to developmental progression could lead to
aberrant rearrangement of a second allele that remains unrepaired. The proliferative
burst that occurs after the pro-B cell or DN thymocyte stages may pose a particular
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hazard in this regard, which may be one reason that allelic exclusion is enforced more
strictly for the IgH and TCRβ chains than for Igκ and TCRα (Brady et al., 2010).
Allelic exclusion and autoimmunity
Although allelic exclusion of antigen receptors was first described over fifty years
ago, its importance is still debated. A long-standing hypothesis posits that allelic
exclusion is required for proper positive and negative selection of developing
lymphocytes (Vettermann and Schlissel, 2010). Central tolerance mechanisms that cull
self-reactive B and T cells depend stimulation of those cells through their cell surface
receptors. In an allelically included cell, the cell-surface concentration of an autoreactive
receptor might be diluted by a
+ second innocuous receptor so that it does not trigger central tolerance mechanisms
that would normally lead to removal of the autoreactive receptor from the repertoire.
However, if the cell later became activated through the innocuous receptor, the activity
of the self-reactive receptor might lead to autoimmune disease (Vettermann and
Schlissel, 2010).
Experimental evidence regarding this idea has been mixed. Several groups have
shown that cells engineered to express antigen receptor chains likely to mediate selfreactivity have shown that co-expression of an endogenous receptor can indeed allow
development of cells carrying self-reactive receptors; however in most cases resulting
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autoimmune disease was not reported, perhaps because peripheral tolerance
mechanisms provided sufficient protection (Iliev et al., 1994; Zal et al., 1996; Gerdes and
Wabl, 2004). In contrast, one study employing transgenic expression of both TCR and
the cognate antigen found that co-expression of an endogenous TCRα chain could allow
T cells to evade tolerance mechanisms and cause diabetes (Sarukhan et al., 1998). A
limitation of all these studies is the extreme overrepresentation of a single self-reactive
receptor, a situation that is not representative of a normal immune system. One study
instead used transgenic expression of an Igκ chain that was not expected to be
particularly self-reactive; this led to a relatively high frequency of Igκ/λ inclusion, but not
to noticeably high levels of autoantibody production or autoimmune disease (Sirac et
al., 2006). Finally, several groups have examined the self-reactivity of naturally occurring
allelically included cells; conflicting results have come from these studies. In studies of
lupus prone mice, one group found that cells expressing two Igκ chains were more likely
than single-expressers to produce autoantibodies, while another group using a different
lupus model found the opposite (Fournier et al., 2012; Makdasi and Eilat, 2013). The use
of two different models suggest that strain differences may account for this
contradiction. It is possible that lapses in other tolerance mechanisms would be
necessary to reveal any increased autoreactive potential possessed by allelically
included lymphocytes.
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Steps toward a new model of allelic inclusion
A tool that has been lacking in this field is a model of increased allelic inclusion in
the absence of other immune system abnormalities. Antigen receptor transgenic models
skew the immune repertoire unnaturally. Unfortunately, although deficiency of either
ATM or Nemo increases allelic inclusion, these mice are also not ideal models. ATM
deficient mice are somewhat lymphopenic, have impaired specific antibody production,
and develop lymphoma by four months of age, all of which confound investigations into
of the effects of allelic inclusion on the immune system (Xu et al., 1996). Nemo-deficient
B cells develop fairly normally but do not die upon reaching maturity (Sasaki et al.,
2006). It is our hope that further elucidation of the signaling events leading to the
suppression of RAG expression and V(D)J recombination will allow a more targeted
disruption of the signal in vivo, increasing allelic inclusion without impairing critical
immune functions.
A first, relatively blunt approach will be to constitutively express Rag1.
Constitutive expression of both Rag1 and Rag2 was previously reported; in this case a
decrease in allelic exclusion was reported, but this might be due to the severe
impairment of B and T cell development reported in these mice (Barreto et al., 2001). It
was surmised that impaired development was due to RAG activity during inappropriate
developmental stages; by constitutively expressing only Rag1 we hope to avoid this
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problem. Our finding that Rag2 protein persists in the presence of DSBs due to its long
half-life suggests that maintaining expression of Rag1 alone will be sufficient to
overcome the transient suppressive signal activated by a RAG-mediated DSB and
promote allelic inclusion. However, a more thorough understanding how Rag1 and Rag2
transcription is suppressed by DSBs might allow us to take a more nuanced approach to
disrupting this signal. For example, if we identify a suppressive factor that turns off
Rag1/Rag2 transcription, it may be possible to mutate its binding site to specifically
prevent suppression of Rag1 and Rag2 expression.
V(D)J recombination and genomic stability
In addition to promoting allelic exclusion, we propose that suppression of Rag
expression and V(D)J recombination serves to limit the probability of antigen receptor
translocation. When antigen receptor loci are involved in translocations, they can drive
the expression of proto-oncogenes and promote malignant transformation (Schlissel,
2006). A translocation necessarily requires DNA breaks at two genomic locations.
Accordingly, it has been formally shown that increasing the frequency of DSBs at a locus
increases the frequency of translocation (Richardson and Jasin, 2000). Therefore,
cleavage of an antigen receptor locus in the presence of a pre-existing DSB is likely to be
particularly risky. The models proposed above to study allelic exclusion will also be
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helpful in testing the hypothesis that suppression of Rag1 and Rag2 expression by DSBs
helps to prevent oncogenic antigen receptor translocations.
Concluding remarks
The work presented in this dissertation shows how developing lymphocytes use
the conserved DNA damage response to address lymphocyte-specific developmental
needs. These data add to our understanding of Rag expression and its role in allelic
exclusion. The ability of DSBs to regulate Rag1 and Rag2 expression in both developing
B and T cells, which otherwise regulate Rag1/Rag2 using largely distinct mechanisms,
suggests that this signal plays an important role in lymphocyte biology.
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Figure 5.1

Figure 5.1: Model of inhibition of V(D)J recombination by DSBs. Left panel shows a
normal situation in which Rag1 and Rag2 are transcribed and produce protein, leading
to RAG-mediated cleavage of an antigen receptor locus. Right panel shows DSB signaling
to suppress V(D)J recombination. Black, solid lines represent signals described in this
dissertation. Gray, dotted lines represent hypothetical signals that might cooperate with
loss of Rag1 and Rag2 transcription and Rag1 protein in suppressing V(D)J
recombination.
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Methods
Mice
All mice used within this study were housed, bred, and used under pathogen-free
conditions at the Children's Hospital of Philadelphia (CHOP). All experiments were
performed using 4-6 week old mice using both male and female mice. Experimental
mice were euthanized by exposure to CO2 followed by cervical dislocation. Animal
husbandry and experiments were performed in accordance with national guidelines and
regulations and approved by the CHOP Institutional Animal Care and Use Committee.
The EμBCL2 (Strasser et al., 1991b) Atm-/- , Mb1Cre+Atmflox/flox(Steinel et al., 2013),
VavCre+p53flox/flox (DeMicco et al., 2013), Mb1Cre+Nemoflox/flox (Derudder et al., 2009)
mice were on a mixed 129S1/SvImJ and C57BL/6 background, while Rag1-/- (Mombaerts
et al., 1992a) and Rag2-/- (Hao and Rajewsky, 2001) mice were on the C57BL/6
background.
Irradiation
All mice were subject to irradiation using an XRAD320 X-ray irradiator (Precision X-Ray)
and a dose rate of 0.74 Gy/min. Primary cells and cell lines were subject to irradiation
using a Gammacell 1000 Cs-137 irradiator (Nordion Inc) and a dose rate of 1.8 Gy/min.
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qRT-PCR quantification of Rag1, Rag2, and p21 mRNAs
Non-irradiated and irradiated cells were harvested at indicated time points and
immediately lysed in Trizol (Life Technologies) and processed according to the
manufacturer's instructions. Isolated RNA was treated with DNase (Promega) according
to manufacturer directions, primed with random nonamers (New England Biolabs, NEB),
and reverse transcribed with M-MuLV (NEB) to generate cDNA. The cDNAs were then
used as template for qRT-PCR reactions were performed with SYBR green mastermix
(Applied Biosystems) and run on an Applied Biosystems 7500 Fast machine. Values were
normalized to housekeeping genes as indicated in the text and fold change was
determined by the ΔΔCT method. The primers used for qRT-PCR reactions are listed in
Table 1. When pre-B cells were subject to irradiation, non-irradiated pre-B cells also
were transported to the irradiator, but not exposed to ionizing radiation along with
irradiated samples. The irradiated and non-irradiated pre-B cells were each placed back
into culture until they were harvested. Since pre-B cells were transported to and from
the irradiator at room temperature, the basal levels of Rag1, Rag2, and p21 mRNAs
were lower at 1 hour after the irradiation time point than at 4 hours after the irradiation
time point.
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Small molecule inhibitors
To inactivate the ATM kinase, the KU55933 ATM kinase inhibitor was added to media at
a concentration of 15 μM. To block new protein synthesis, the ribosome inhibitor
cycloheximide was added to media at a concentration of 10 μg/mL. To block protein
degradation, the proteosome inhibitor MG132 was added to media at a concentration
of 10 μM. To inhibit IKKβ either 5μM BMS-345541 or 20μM ML120B was used. To
induce DSBs by genotoxic drugs, etoposide was added to the media at a concentration
of 10 μg/mL or bleomycin was added at a concentration of 5 μM.
Primary pre-B cell cultures
Primary bone marrow (BM) cells were harvested by flushing BM from all leg bones of at
least four mice of the appropriate genotype for each experiment. These BM cells were
cultured for 3-5 days in RPMI supplemented with 10% FBS, 10 mM HEPES, 1 x nonessential amino acids, 1 mM L-glutamine, 1 mM sodium pyruvate, 100 U/mL pen-strep,
30 μM β-mercaptoethanol and 50 ng/mL IL-7. Cells were plated at a density of 5 million
cells per mL of media. Each day, cells were harvested and put back into culture in fresh
media at a density of 5 million cells per mL. To induce G1 arrest and activate
transcription of Rag1 and Rag2 by IL7 withdrawal, cells were pelleted by centrifugation,
re-suspended in the same media lacking IL7 at a density of 5 million cells per mL, and
treated as described for each experiment.
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Western blots
Pre-B cells were washed with PBS and re-suspended in ice cold lysis buffer (20 mM Tris
pH 7.4, 20 mM glycerol phosphate, 10 mM sodium orthovanadatem, 10% glycerol, 0.5
mM EDTA, 0.5 mM MgCl2, 200 mM NaCl, and 0.2% Triton-X) and then sonicated at
intervals of 30 seconds on and 30 seconds off for 8 minutes at 4°C. The sonicated cells
were incubated on ice for 10 minutes and then centrifuged to remove insoluble
material. Laemmli buffer was added and then samples were boiled for 5 minutes.
Lysates from equivalent numbers of pre-B cells were loaded and run on NuPage trisglycine gels (Life Technologies). Electrophoresed proteins were transferred to
Immobilon-FL PVDF membrane (EMD Millipore). Membranes were blocked with
Odyssey blocking buffer (Li-Cor) according to manufacturer’s instructions. Antibodies
used are: anti-Rag1 or anti-Rag2 monoclonal antibody (Coster et al., 2012); anti-actin
antibody (Sigma AV40173); anti-Gadd45α (Santa Cruz sc-797); anti-phospho IKKα/IKKα
(Cell Signaling Technology 2697S); anti-IKKα/IKKα (Santa Cruz sc-7607). Blots were
washed and incubated with appropriate IRDye800 secondary antibodies (LiCor)
according to manufacturer’s instructions. After washing, blots were scanned on an
Odyssey infrared scanner (Li-Cor).
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Click-It analysis of Rag1 and Rag2 mRNA turnover and Rag1 and Rag2 transcription
These assays were conducting using Click-It® Nascent RNA Capture kits (Life
Technologies). For mRNA turnover assays, ethynyl uridine (EU) was added to medium of
IL7 withdrawn pre-B cell cultures at a final concentration of 0.2 mM for the final 16
hours of culture time. Pre-B cells were washed, placed into media lacking EU, and then
split into pools that were immediately irradiated or left non-irradiated. Cell pools were
collected for RNA isolation immediately before EU removal or at indicated times after
EU removal or EU removal and irradiation. For transcriptional assays, pre-B cells were
grown in media lacking EU. Cultures were split into pools that were either irradiated or
left non-irradiated. Immediately after irradiation of some pools, EU was added to the
media of all pools at a final concentration of 0.5 mM. After the indicated times, cells
were collected for RNA isolation. For both assays, RNA was isolated using Trizol (Life
Technologies) according to the manufacturer's instructions. Click chemistry and
streptavidin pull down of EU-labeled RNA were performed according to the Click-It
Nascent RNA Capture kit’s instructions. Pulled-down RNA was reverse transcribed and
analyzed by qRT-PCR as described above. The loading controls for mRNA turnover and
transcription experiments were 18S RNA and Hprt mRNA, respectively.
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Abelson pro-B cell cultures
The EμBCL2 (A2) and Artemis-/-EμBCL2 (Art2.1) Abelson transformed and immortalized
pro-B cell lines were previously described (Bredemeyer et al., 2006; Savic et al., 2009).
We made the EμBCL2-pINV Abelson pro-B cell line using the same procedures that we
previously used to generate cell lines with recombination substrates (Gapud et al.,
2011). Abelsons pro-B cells were cultured in RPMI media supplemented with 10% FBS,
100 U/mL pen-strep, and 30 μM μ-mercaptoethanol To induce G1 cell cycle arrest,
differentiation into pre-B cells, expression of Rag1 and Rag2 mRNA, and V(D)J
recombination, 5 μM STI571 was added to the culture media.
Southern blot analysis of Jκ cleavage
Southern blotting was performed as described (Savic et al., 2009). Briefly, 15-20 μg of
genomic DNA was digested with Sac1-HF (NEB) and EcoR1-HF (NEB). Southern blot
membranes were probed with a 3’Jκ probe and then a 5'Hprt probe as a loading control.
The intensities of bands were quantified using ImageJ software (NIH). For Artemis-/EμBLC2 cells, the percentage of Jκ cleavage at each time point was calculated by dividing
the total intensities of Jκ coding end bands by the combined intensities of the germline
Jκ band and Jκ coding end bands (Yin et al., 2009). For EμBLC2 cells, the percentage of Jκ
cleavage at each time point was calculated by dividing the intensity of the germline Jκ
band by the intensity of the 5'Hprt control band.
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Flow cytometry for pMX-INV rearrangement
For analysis of GFP expression in EμBCL2-pINV cells, cells were washed in FACS buffer
(PBS with 3% FCS and 0.25 mM EDTA) and then stained with PE-conjugated anti-human
CD4 antibody (BD Pharmigen, clone RPA-T4) to stain cells containing the substrate. Flow
cytometry was conducted using an LSR-II flow cytometer (BD Biosciences) and data was
analyzed using FlowJo 10.
Flow cytometry for IgM allelic inclusion
Stains were conducted using the following Abs or reagents: FITC-anti-IgMa (DS-1; BD
Biosciences), PE-anti-IgMb (AF6-78; BD Biosciences), Biotin-anti-CD23 (B3B4; BD
Biosciences), PerCP/Cy5.5 anti-CD21/35 (7E9; BioLegend), and PE/Cy7-SA (BD
Biosciences). Flow cytometry was conducted using an LSR-II flow cytometer (BD
Biosciences) and data was analyzed using FlowJo 10. Surface IgM expression was
assayed on singlet, live, B220+ cells.
Flow cytometry for intracellular TCRβ allelic inclusion
Surface stains were conducted using the following Abs or reagents from BD Biosciences:
PE-anti-B220 (RA3-6B2), APC-anti-TCRβ (H57-597), V450-anti-CD4, TxRed-anti-CD8, .
After surface staining, cells were permeabilized using BD Fix-Perm solution according to
the manufacturer's instructions. After permeabilization cells were stained with
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combinations of FITC or biotin conjugated: anti-Vb5 (MR9-4), anti-Vb14 (14-2), anti-Vb8
(F23.1), anti-Vb4 (KT4), anti-Vb6 (RR4-7), anti-Vb12 (MR11-1), and PE/Cy7-streptavidin.
Flow cytometry was conducted on an LSR-II flow cytometer (BD Biosciences) and data
was analyzed with FlowJo 10. Internal Vβ expression was assayed on singlet, live, cells.
Stimulation of αβ T cells for generation of hybridomas and for two-color fluorescence
in situ hybridization assays
Single-cell suspensions were isolated from the spleens of 6-wk-old mice and depleted of
RBCs with NH4Cl lysis buffer prior to stimulation. Each spleen was stimulated for 48 h in
40 U/ml IL-2 and 5 mg/ml Con A at 4 ml/spleen in DMEM containing 15% FBS, 1%
penicillin/streptomycin, 1% L-glutamate, and 30 mM β-mercaptoethanol. Additional
medium was added to the stimulation after 24 h.
Two-color fluorescence in situ hybridization assay
T cells stimulated for 48 h were arrested in metaphase by incubating with colcemid
(KaryoMax) and 0.45 mM BrdU (Sigma-Aldrich) for 2 h. Metaphase-arrested cells were
isolated by hypotonic treatment (40 mM KCl, 0.5 mM EDTA, and 20 mM HEPES [pH 7.4])
and fixation in methanol:acetic acid (3:1 volume). The fixed cells were dropped on slides
at 4°C and dried at 75°C for 5 min. Metaphase spreads were hybridized overnight with
Tcrb bacterial artificial chromosome probes Vb-DbJb1, RP23-203H5 and Cβ, 164G11. Cβ
probe was labeled using DIG-NICK Translation Mix (Roche). Vb-DbJb1 probe was labeled
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using BioPrime DNA Labeling System (Invitrogen). Probes were detected using FITC-antidigoxin Fab (Roche) and Texas Red-streptavidin (Vector Laboratories). Coverslips were
mounted with Vectasheild mounting medium with DAPI (Vector Laboratories). Images
were captured and analyzed using Case Data Manager (Applied Spectral Imaging).
Fusion and Analysis of T Cell Hybridomas
αβ T cell hybridomas were produced by fusion of ConA and Il-2 stimulated T cells
with BW-1100.129.237 thymomas. Southern analyses of Tcrβ rearrangements were
performed as previously described (Khor and Sleckman, 2005).
PCR Analysis and Sequencing of Vβ Rearrangements in Hybridomas
Hybridoma genomic DNA was isolated and Vβ rearrangements were amplified by PCR
using Vβ-specific primers and 3’Jβ1.2 primer (P2) as previously described (Bassing, Alt
et al. 2000; Steinel, Brady et al. 2010). PCR products were resolved on a 1% agarose gel
to identify which Vβs were utilized. PCR products were purified (Qiagen, QIAquick
PCR Purification Kit, 28104) and sequenced using the 3’Jβ1.2 primer (P2).
Statistical analyses
All statistics were generated using GraphPad Prism 5 or Prism 7 software.
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Table 1: qPCR primers
18S F
CGCGGTTCTATTTTGTTGGT
18S R
AGTCGGCATCGTTTATGGTC
β actin F
TCATCACTATTGGCAACGAGCGGTTC
β actin R
TACCACCAGACAGCACTGTGTTGGCA
CD19 F
ACCAGTACGGGAATGTGCTC
CD19 R
TTCATAGGCCTCCCCTTCTT
Gadd45α F CCGAAAGGATGGACACGGTG
Gadd45α R TTATCGGGGTCTACGTTGAGC
Hprt F
CTGGTGAAAAGGACCTCTCG
Hprt R
TGAAGTACTCATTGTAGTCAAGGGCA
Lck F
CCTTCGGGATCTTGCTTACA
Lck R
GTTGTCAGGTCTCACCATGC
p21 F
GACATTCAGAGCCACAGGCAC
p21 R
GTCAAAGTTCCACCGTTCTCG
Rag1 F
TGGGAATCGTTTCAAGAGTGAC
Rag1 R
CATCTGCCTTCACGTCGATCC
Rag2 F
ACACCAAACAATGAGCTTTCCG
Rag2 R
CCGTATCTGGGTTCAGGGAC
Spic F
AAACATTTCAAGACGCCATTGAC
Spic R
CTCTGACGTGAGGATAAGGGT
Wasp F
GCTCCCTCCTACTCCAGTGTC
Wasp R
AGGGCACCTACTAGGCCTTC
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